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Shock or severe cardiac failure developing in the course of 
acute myocardial infarction is an ominous event with a grave 
prognosis. Despite its frequent occurrence, the precise haemodynamic 
alterations which occur in cardiogenic shock have not been clearly 
defined. To date there is no uniform agreement about the therapeutic 
management of these severely ill patients and the widely different 
therapeutic measures being advocated only emphasise the uncertainty 
about the precise pathogenesis of shock complicating acute myocardial 
infarction. 
This thesis reviews developments in the concept of myocardial 
infarction and describes haemodynamic and respiratory studies in 
patients with acute myocardial infarction. 
The investigations show that nearly all patients with recent 
myocardial infarction have abnormal cardio -respiratory function. 
Even in patients with so called 'uncomplicated' myocardial infarction 
cardiac output is in the low normal range and the mixed venous 
oxygen saturation is reduced. A number of these patients have a 
raised pulmonary arterial pressure. Mismatching of ventilation and 
perfusion results in arterial hypoxia. The clinical diagnosis of 
left ventricular failure is not always easy and the abnormal 
cardio- respiratory function suggests that sub -clinical left 
ventricular failure is a relatively common finding in acute 
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myocardial infarction. 
In patients with cardiogenic shock or clinical left ventricular 
failure, the disorders of cardiac and pulmonary function are more 
marked but the similarity of the abnormalities suggests that left 
ventricular failure is present in both groups. The finding of raised 
pulmonary arterial pressures in the patients with cardiogenic shock 
is in accord with this view. In general the more severely ill the 
patient the greater is the degree of cardiac failure and respiratory 
abnormality. 
The thesis also documents attempts to treat the impaired left 
ventricular function in cardiogenic shock by digitalis and acid -base 
correction and comments on the failure of this approach. 
The failure to alter the course of cardiogenic shock by 
pharmacological agents is similar to the reports of many other 
investigators. Pain and anxiety are present in many of these patient 
and this can be relieved by opiates, but recent reports have 
suggested that morphine can produce marked hypotension in patients 
with acute myocardial infarction and that morphine should be used 
with great caution, if at all. A detailed examination of the 
circulatory effects of morphine and heroin in myocardial infarction 
is presented. The results suggest that morphine is a suitable 
analgesic for the relief of pain in acute myocardial infarction. 
INTRODUCTION 
Intensive care and therapy units are now well established in 
the management of acute myocardial infarction. They do reduce the 
mortality from serious arrhythmias, possibly by prevention, but 
certainly by effective therapy. However, the improved management 
of arrhythmias has focussed attention on the major remaining problem, 
that of shock and severe heart failure complicating acute myocardial 
infarction. 
Of the first 400 cases of myocardial infarction admitted to 
the Coronary Care Unit of the Royal Infirmary of Edinburgh, there 
were 70 deaths (17.5 %). 32 of these deaths occurred in patients 
who were graded as being shocked and 9 deaths occurred in patients 
with persistent failure. (Lawrie, Greenwood, Goddard, Harvey, 
Donald, Julian and Oliver, 1967) (Oliver, Julian and Donald, 1967). 
Thus the majority of deaths in patients with myocardial infarction 
admitted to hospital occurred in patients with shock or severe 
failure. If there is to be further improvement in the care of acute 
myocardial infarction, a major area of concern must be in the 
understanding of the mechanism of shock and failure complicating 
this condition so that a rational therapeutic approach can be planne 
Acute myocardial infarction is frequently followed by a fall 
in blood pressure and in a number of patients this is associated 
with the clinical signs of shock. The proportion of patients in 
whom this complication arises, has varied widely from one centre to 
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another because of varying criteria for the definition of shock. 
In general when the criteria are stringent, the incidence of shock 
is lower and the mortality higher. Freidberg (1961) reviewed the 
incidence of shock in 2,955 cases of acute myocardial infarction in 
10 reported series and noted the incidence to be 14% with a 
mortality of 79% when strict criteria were applied, but 52% incidenc 
with a 36% mortality when the less strict criteria were used. The 
use of inadequate criteria for the diagnosis of cardiogenic shock 
has led to many therapeutic claims which have not been confirmed 
by subsequent workers. Strict criteria are essential if therapeutic 
results are to be compared between different centres. 
In the Coronary Care Unit of the Royal Infirmary of 
Edinburgh, we have continued to use the criteria described by 
MacKenzie in 1965. His diagnosis of cardiogenic shock was based 
on the findings of a systolic blood pressure on auscultation of 
less than 100 mm Hg in the presence of cold, clammy, sweating and 
cyanosed extremities with associated clouding of consciousness, 
usually manifested as mental apathy or restlessness. Using such 
criteria the incidence of shock in the Coronary Care Unit of the 
Royal Infirmary of Edinburgh was 9% of admissions with acute 
myocardial infarction and the mortality in this group was 83% 
(Lawrie et al., 1967). The incidence and mortality pattern suggest 
that such diagnostic features provide stringent criteria for 
defining shock. 
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Nevertheless, the criteria are largely subjective and there 
is a great need to find a relatively simple objective measurement 
of the patient's circulatory state to aid in the clinical assessment 
and to provide documentation about claimed therapeutic success. 
In the treatment of cardiogenic shock, various therapeutic 
measures such as intravenous transfusion, intra- arterial transfusion 
cardiac glycosides, vasopressors, vasodilators and assisted 
circulation have been suggested. To date there is no uniform 
agreement about therapeutic management thus emphasising the wide 
divergences of opinion regarding the pathogenesis of shock 
complicating acute myocardial infarction. 
This thesis is presented as an account of the cardio- 
respiratory status of patients with varying grades of severity of 
acute myocardial infarction and describes the abnormal physiology 
of shock in relation to that of other patients with myocardial 
infarction without shock. It documents therapeutic manouevres which 
were carried out to treat the patients with cardiogenic shock and 
an examination of their response to such therapy, gives additional 
information about the patho -physiology of this condition. 
Cardiogenic shock was a term used by Harrison (1935) to describe 
shock occurring in a variety of conditions of shock in which the 
heart might be implicated. Most workers restrict the term to shock 
complicating acute myocardial infarction, but confusion about 
pathogenesis and therapy still exist because some of the claims for 
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therapeutic success have been documented in other types of shock, 
particularly the low output state following cardio -pulmonary bypass 
(Dietzman and Lillehei, 1968). In this thesis the term cardiogenic 
shock will be restricted to shock complicating acute myocardial 
infarction; furthermore as shock may complicate arrhythmias and be 
reversed following the successful treatment of the arrhythmia, the 
term cardiogenic shock will be reserved for those patients in 
basically sinus rhythm. 
The thesis is presented in six chapters. Chapter I is a 
review of developments in concepts of myocardial infarction. Also 
considered are studies of altered physiology in acute myocardial 
infarction with particular reference to patients who are judged 
clinically to be severely ill. In Chapter II there is a general 
outline of techniques and investigational methods used in the work 
reported in this thesis. Each of the remaining chapters will report 
the results of studies and will present relevant discussion. Chapter 
III will present detailed results of circulatory and respiratory 
studies in acute myocardial infarction of varying grades of severity. 
Chapter IV will report the results of therapy with digoxin, acid -base 
correction and volume loading in patients with cardiogenic shock. 
There is often only a poor response to therapy in severe 
grades of acute myocardial infarction. Opiates do provide relief 
of pain but a report by Thomas, Malmcrona, Fillmore and Shillingford 
(1965) suggested that the traditional regime of morphine could 
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produce marked hypotension and that morphine should be used with 
great caution if at all. Chapter V describes the circulatory effects 
of morphine in patients with acute myocardial infarction and compares 
these effects with previously published results on the circulatory 
effects of heroin (MacDonald, Rees, Muir, Lawrie, Burton and Donald, 
1967). 
As the comparison showed little real difference between the 
two opiates and was in conflict with the report of Thomas and his 
colleagues, a second more detailed comparison of these two opiates 
was made using a randomised patient allocation, a 'blind' 
administration schedule and newer and more sensitive statistical 
techniques. This study is reported in Chapter VI. 
The main conclusions and recommendations concerning the 
management of patients with shock complicating myocardial infarction 
are contained in the final summary. 
DEVELOPMENTS IN THE CONCEPTS OF MYOCARDIAL INFARCTION 
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CHAPTER I 
Although coronary artery disease has become one of the major 
diseases of the 20th Century, it is difficult to be certain whether 
this disease was prevalent in earlier times. Chest pain is mentioned 
by William Harvey in a letter to Riolan (1649) when he described 
"a man who did often complain of an oppression in his breast" - "at 
last opprest in a signal paroxism he died ". However, the autopsy 
showed aortic stenosis and a rupture of a large left ventricle. 
There must also be doubt about the role of coronary artery disease 
in a case described by Giovanni Maria Lancisi who, whilst 
investigating the causes of sudden death in Rome in 1707, noted one 
"obese gouty,plethoric person" with praecordial pain who died at a 
meal. Autopsy showed a pericardial sac full of blood from the 
rupture of an aneurysm. Lancisi quoted Hippocrates as saying "pain 
in the heart coming rather often means sudden death ". Neither Harvey 
nor Lancisi attributed the pain to disease of the coronary arteries. 
Studies in palaeopathology also fail to determine whether 
coronary artery disease occurred in earlier centuries. Atheroma in 
the aorta has been noted in mummies from all Egyptian dynasties 
(Ruffer 1921) but there are no accounts of pathology in the coronary 
arteries. Contrary to the view of Oliver (1954) this is not because 
the heart was removed at the time of mummification. The ancient 
Egyptians believed the heart was the seat of the soul and in nearly 
all dynasties the heart was thrust back into the thoracic cavity at 
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the time of evisceration. Mummification was inadequate to preserve 
the heart and coronary arteries (Buffer 1921). 
The history of coronary artery disease probably starts with 
Heberden's precise account of the symptomatology of angina pectoris 
to the College of Physicians in London in 1768. Heberden had not 
linked the anginal pain with coronary artery disease; this relation- 
ship was first mentioned by Jenner but he delayed publication for 
fear of alarming John Hunter, in whom he had diagnosed angina pect- 
oris (Bedford 1968). By 1799 Parry had published his "Inquiry into 
Syncope Anginosa" and this coronary theory was also supported by 
Burns in his text book on heart disease (1809). 
Over the next 100 years the recognition of coronary heart 
disease became obscured by a number of controversies and under 
Laennec's influence the concept of fatty degeneration of the heart 
was widely held to be the cause of chest pain. It was not until the 
end of the 19th Century that Weigert (1880) and Zeigler (1881) est- 
ablished the ischaemic basis of acute infarction and fibrosis and 
related them to coronary occlusion. Despite confusion about the 
aetiology of anginal pain during the 19th Century in the medical 
literature, ideas about the course of the disease had permeated lay 
literature. George Eliot in 'Middlemarch' made Dr. Lydgate say to 
Mr. Casaubon 'My conclusions are doubly uncertain; uncertain not 
only because of my own fallibility but because diseases of the heart 
are eminently difficult to form predictions on. I believe you are 
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suffering from what is called fatty degeneration of the heart 
It is my duty to inform you that death from this condition is often 
sudden. At the same time no such result can be predicted. Your 
condition may be consistent with a tolerably comfortable life for 
another fifteen years or more ". 
By the end of the 19th Century the concept of coronary artery 
disease as a major cause of illness was being discussed. Gibson and 
Muir (1894) reported a case of cardiac fibrosis as a result of cor- 
onary obstruction in a patient admitted to Ward 22 of the Royal 
Infirmary, Edinburgh. In the discussion of their paper they drew 
attention to the presence of praecordial pain and at autopsy "to 
the narrowing of the coronary arteries which become obliterated or 
thrombosed and cause infarction of the heart wall - soft necrosed 
areas which form the condition known as myomalacia cordis". 
The most complete early description of the syndrome of myo- 
cardial infarction was not until Herrick's paper of 1912. The wide- 
spread recognition of the disease followed Herrick's second paper in 
1918 and Pardee's description of electrocardio- graphic changes in 
1920. The first large series of cases was reported by Levine and 
Brown in 1929 in an extensive paper in which they analysed the clin- 
ical features of 145 cases of coronary thrombosis and pathological 
data of 46 of these. Their main conclusions were that angina pect- 
oris generally precedes attacks of coronary thrombosis but in some 
cases there was no history of angina nor of any other pre -existing 
disease. They showed that coronary thrombosis was common in diab- 
etics and also noted transient glycosuria in many patients at the 
time of infarction. Hypertension was often a pre- existing disease. 
They drew attention to the distribution of the pain, the fever and 
leucocytosis and to physical signs of pericardial friction rub and 
riles in the lungs. Whilst discussing modes of death they described 
patients who have "general failure of the circulation Here the 
shock to the circulation is sufficient to depress the blood pressure 
to very low levels such as 60 or 80 mm, or the pulse may be 
imperceptible. The patient then presents the picture of profound 
shock and may be actually unconscious". 
The first study of circulatory dynamics in myocardial 
infarction was reported by Fishberg, Hitzig and King (1934). They 
studied venous pressure, measured peripherally, circulation time 
measured as arm to tongue time and volume of circulating blood using 
congo red in 59 patients. In all cases of massive infarction they 
noted the clinical features of shock which they described as: 
greyish acrocyanois, cold extremities, moist skin, superficial 
respiration which may or may not be rapid, but no orthopnoea; 
collapsed superfical veins and a pulse which is often most rapid, 
small and of low tension. They recorded that these shocked patients 
had low venous pressures and a low circulating blood volume. The 
very nature of their investigative techniques must cast some doubt o 
their findings but it is curious that their conclusions that cardiac 
failure and shock in myocardial infarction operate from differing 
mechanisms one from circulatory overload and one from volume depleti 
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is an argument that still divides clinicians treating patients with 
acute myocardial infarction. Fishberg modified his views later when 
he stated that the clinical picture of shock in myocardial infarction 
was the result of a marked decrease in cardiac output from acute 
myocardial failure (Fishberg 1940). Such a view was also held by 
Stead and Ebert (1942). In a study of venous pressure, arm to tongue 
circulation time and plasma volume measured by Evans blue,in 
cardiogenic shock, they observed that despite the absence of dyspnoea 
and in the presence of low venous pressures the chest x -ray always 
showed pulmonary congestion. However, the plasma volume was slightly 
smaller than predicted volumes. In 2 subjects venesection of 
500 c.c. of blood caused neither clinical improvement nor a change 
for the worse. They concluded that there was imbalance of the 
circulation and that because of infarction of muscle the heart was 
unable to respond to Starling's law of the heart. 
Cardiac output in acute myocardial infarction was first 
measured by Grishman and Master (1941) using the Wezler -Boeger 
method based on analysis of the pulse pressure and pulse wave 
velocity. They recorded cardiac outputs ranging from 3.15 to 5.9 
litres /min in 5 patients with infarction but without shock. Starr 
and Wood (1943) also studied cardiac output in patients with infarcti 
but their technique was that of ballisto- cardiography. They 
concluded that in acute infarction, cardiac output was either normal 
or below normal but not as low as that of patients who suffered from 
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angina pectoris. 
In 1950 Pritchard and Hellerstein reported the results of cardi 
outputs determined by the Fick method in 11 patients with acute 
myocardial infarction but without shock: cardiac outputs were in the 
lower ranges of normal. To calculate the arteriovenous oxygen 
difference, they sampled venous blood from the great veins; oxygen 
sampling from a central vein has been criticised as an inadequate 
guide to true mixed venous blood oxygenation (MacKenzie 1965). 
Recently Scheinman, Brown and Rapaport (1969) showed that venous 
oxygen saturations collected from atrial level correlated quite well 
with pulmonary arterial blood in patients with uncomplicated 
myocardial infarction, but in patients who were severely ill with 
failure or shock the correlation between saturations from the great 
veins and the pulmonary artery was much less close. As the patients 
studied by Hellerstein and Pritchard were in the uncomplicated group, 
their output determinations may not have been seriously in error. 
The first comprehensive circulatory investigation of acute 
myocardial infarction was reported by Freis, Schnapper, Johnson and 
Schreiner (1952), They studied 11 patients, 4 of whom were 
uncomplicated, 5 were moderately severe or severe and 4 had the 
features of shock. The 5 moderately severe or severe had clinical 
features of left ventricular failure. Arterial pressure was measured 
intravascularly from the femoral artery and cardiac output 
was measured with a dye dilution technique using Evans blue (T 1824) 
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as an indicator. Their results are summarised in table I and showed 
that the more severe the infarction the lower was the cardiac output 
and stroke volume. The authors suggested that the primary event in 
cardiogenic shock was a reduction in left ventricular output. 
Smith, Wikler and Fox (1954) reported a similar study in which 
they had examined the circulatory status of 10 patients without shock 
and 9 patients with shock. Cardiac output was measured by the 
indicator dilution technique with intermittent arterial sampling, but 
whereas Freis and colleagues had injected dye into the great veins in 
the study of Smith, Wikler and Fox the dye (T 1824) was injected into 
the femoral vein or antecubital vein. The possible 'peripheral 
trapping' of dye with forearm injection increases the error in dye 
dilution estimations of cardiac output. The point is of some 
importance as the findings of Smith and colleagues suggested that 
cardiac output was equally low in patients without evidence of shock 
and that the reduction in cardiac output was only one of the features 
that determined the clinical appearance of the patient. Blood volume 
studies revealed no significant deviation from the normal. 
Gilbert, Goldberg and Griffin (1954) and Gammil, Applegarth, 
Reed, Fernald and Antenucci (1955) reported on the haemodynamic 
features in acute myocardial infarction. Cardiac output determinatio 
were again made by intermittent arterial sampling of peripherally 
injected dye. Both groups concluded that the degree of reduction of 
cardiac output was roughly proportional to the clinical severity of 
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the attack. Despite the observations by Freis et al. (1952) of the 
surprisingly large differences between blood pressure measured intra- 
arterially and by sphygmomanometry, Gammil and colleagues measured 
blood pressure by sphygmomanometer. 
There were further reports of haemodynamics in myocardial 
infarction by Lee (1957), Broch, Humerfelt, Haarstad and Mylvie (1959 
and Murphy, Glick, Schreiner and Yu (1963) (Table I). These reports 
tended to confirm the findings of low cardiac output in the severely 
ill. Lee's study merits special comment. He studied 11 patients 
whom he graded arbitarily in clinical severity O -4. Grade 0 
represented uncomplicated myocardial infarction and grade 4 the full 
shock syndrome. Only 1 patient fell into grade 4, but 4 patients 
were in grade 3, with most of the features of shock. Cardiac output 
was measured using a dye dilution technique with T 1824 as an indicat 
and the dilution curve was obtained by intermittent arterial sampling 
His measured cardiac outputs corrected for bor surface area were 
higher than others had recorded, but were reduced in patients who 
were severely ill. Central venous pressures were elevated and 
forearm blood flow was approximately half normal. He also recorded 
that there was no overshoot to the Valsalva manoeuvre in the most 
severely ill. He noted the apparent paradox that despite circulatory 
evidence of heart failure clinical signs of pulmonary oedema were 
absent or slight. He evoked a " Bernheim" effect with pressure from 
the left ventricle impairing right ventricular function and resulting 
in some sparing of the pulmonary system in spite of a failing left 
ventricle. 
MacKenzie, Taylor, Flenley, MacDonald, Staunton and Donald 
(1964) and MacKenzie (1965) working from the Department of Medicine 
of the Royal Infirmary, Edinburgh, described a series of 9 patients 
with uncomplicated myocardial infarction, 2 patients with left 
ventricular failure and 6 patients with cardiogenic shock. In a 
detailed and careful study they confirmed the earlier observations 
of reduction of cardiac output in the severely ill, but again noted 
that equally low values were found in some cases of myocardial 
infarction without shock. There was no such overlap in stroke volume 
and they suggested that in cardiogenic shock, patients were sometimes 
able to maintain cardiac output by an increase in heart rate. Patien 
with shock had high right atrial pressures. Such a reduction in 
stroke volume in the absence of apparent hypovolaemia suggested a 
severe impairment of left ventricular function. MacKenzie (1965) 
also showed a reduction of various measurements of myocardial 
performance such as maximum rate of pressure rise in the aorta, mean 
ejection -flow index and stroke -power index implicating failure of the 
left ventricle as a pump. 
In addition MacKenzie and his colleagues drew attention to the 
arterial hypoxia that existed in the shocked patients and that the 
administration of oxygen failed to cause a normal increase in arteria 




blood was being shunted through the lungs without coming into contact 
with gas exchanging units in patients with cardiogenic shock. These 
patients also exhibited a marked metabolic acidosis with lacticacid- 
aemia. MacKenzie postulated that this severe metabolic acidosis 
might cause a reduction in myocardial contractility and also cause 
a refractoriness to the action of drugs such as digitalis. As the 
current study was conducted using the same diagnostic criteria and 
similar equipment and techniques as those used by MacKenzie and his 
colleagues the haemodynamic data from their study will be presented 
along with the data from the present investigation. 
Following the observations of MacKenzie et al. (1964) there 
were a number of reports of blood gas changes and pulmonary function 
in acute myocardial infarction. McNicol, Kirby, Bhoola, Everest 
and Freedman (1965) divided their patients into 4 groups. Group I 
consisted of 14 patients with uncomplicated myocardial infarction, 
in group 2 there were 2 patients with myocardial infarction and 
shock, the 13 patients in group 3 had shock and pulmonary congestion 
and in group 4 there were 44 patients with myocardial infarction and 
pulmonary congestion. They found arterial hypoxaemia in all patient 
with pulmonary congestion. In contrast to the findings of MacKenzie 
and colleagues (1964), they found it was possible to influence the 
hypoxia of shock not only by oxygen therapy but also by diuretics. 
They concluded that the arterial hypoxaemia was due to severe vent- 
ilation perfusion imbalance and that the more severe the hypoxia, 
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the more likely it was to be relieved. In a further paper from the 
same group (Kirby and McNicol, 1966) they confirmed the finding of a 
severe metabolic acidosis in the more severely ill. As they presen- 
ted no haemodynamic studies and their clinical groupings were not 
the same as used by previous workers (Freis, et al. 1952, MacKenzie 
et al. 1964), their data is not strictly comparable with the studies 
of MacKenzie and colleagues, nevertheless their studies provided 
useful confirmatory evidence of the hypoxaemia and metabolic acid- 
osis in severely ill patients. 
Blood gas changes after acute myocardial infarction were also 
reported by Valentine, Fluck, Mounsey, Reid, Shillingford and 
Steiner (1966). They again confirmed the arterial hypoxia in pat- 
ients with acute myocardial infarction and by measuring mixed venous 
blood were able to show reduction of venous oxygen saturation in all 
patients. All their patients had an increase alveolar to arterial 
oxygen gradient and venous admixture (Qva) was increased. However, 
after oxygen breathing in 7 patients there was an increase in art- 
erial oxygen tension to greater than 396 mmHg in all patients and 
therefore the "true shunt" (Qs) was small. The patients studied 
were not seriously ill and their observations do not conflict with 
those of MacKenzie (1965). 
A further study of factors influencing pulmonary gas exchange 
during the acute stages of myocardial infarction was reported by 
Higgs (1968). She studied 17 male patients during the acute stage 
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and found the dead space to tidal volume ratio (Vd /Vt) was increased 
and that the arterial oxygen tension was reduced in all patients. 
Venous admixture was greater than normal both when air or 100 oxygen 
was breathed. In the presence of pulmonary congestion, venous 
admixture was as great as 50% when breathing air and fell to 20% 
whilst breathing oxygen. An imposed increase in tidal volume while 
breathing air decreased the abnormal Vd /Vt and increased the arterial 
oxygen tension. These results showed the hypoxaemia to be due to a 
combination of ventilation perfusion imbalance and intra- pulmonary 
shunting presumably past groups of atelectatic alveoli or those fille 
with oedema fluid. The abnormalities were greatest in patients 
with pulmonary congestion. Similar findings were reported by Pain, 
Stannard and Sloman (1967) who emphasised that not all of the 
ventilatory disturbance was due to an imbalance of ventilation and 
perfusion but that in some patients there was quite marked veno- 
arterial shunting. 
Right heart pressures in acute myocardial infarction were 
reported by MacDonald, Rees, Muir, Lawrie, Burton and Donald (1967) i 
a report on the circulatory effects of heroin. One patient with 
shock and left ventricular failure had a high mean pulmonary arterial 
pressure (38 mm Hg). A larger series of cases (26 patients) was 
reported by Fluck, Valentine, Treister, Higgs, Reid, Steiner and 
Mounsey (1957). A raised systolic pulmonary arterial pressure was 
found in 21 patients. This pressure returned to normal by the end 
of a week in all but 3 patients who remained in left ventricular 
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failure. Radiological evidence of pulmonary oedema was seen in 9 
patients in all of whom pulmonary arterial pressure was raised on 
admission. These patients had the greatest reduction in arterial 
oxygen tension. The authors did not attempt to classify their patient 
but analysis of their results indicates that few of their patients 
were severely ill and no patient was shocked. 
Following the observations of arterial hypoxaemia in acute 
myocardial infarction there were a number of studies of the effects 
of oxygen therapy. MacKenzie et al. (1964) had noted that oxygen 
administration in patients with uncomplicated myocardial infarction 
caused a slight reduction in heart rate and cardiac output but an 
increase in arterial blood pressure and systemic vascular resistance. 
In patients with cardiogenic shock, there was a variable response to 
oxygen therapy although in 1 patient cardiac output and systemic 
arterial pressure were increased by significant amounts. The 
abnormally low arterial oxygen tensions obtained breathing 100% oxygen 
in these patients have already been noted. Cameron, Hutton, Kenmure. 
and Murdoch (1966) reported on the haemodynamic and metabolic effects 
of hyperbaric oxygen in myocardial infarction, 2 of their patients 
fit the clinical description of shock. Cardiac output was measured 
using an ear -piece technique. In the 2 shocked patients, cardiac 
outputs were low, arterial hypoxia was present and arterial blood 
lactates were elevated. After therapy with oxygen at 2 atmospheres 
hypoxia was relieved and blood lactates were reduced but not 
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to normal levels. However, oxygen therapy at 2 atmospheres did not 
seem to influence the eventual outcome. 
Foster, Casten, Reeves and Hurst (1969) studied the effects 
of oxygen breathing in 13 patients with myocardial infarction with- 
out failure or shock. The patients breathed 4 different levels of 
inspired oxygen (20.8 %, 47.1 %, 60.4% and 73.5 %) and changes in 
haemodynamics and the chemical and blood gas responses to oxygen 
were noted. They compared their findings with the responses of a 
group of normal subjects. The patients with infarction had a lower 
mean arterial oxygen tension which did not rise as high as did the 
normal subjects with increasing concentrations of inspired oxygen. 
The patients with a lower cardiac output had a arterial oxygen 
tension than patients with high cardiac outputs. There was an 
increase in peripheral resistance and blood pressure with increasing 
concentrations of oxygen in inspired air. They noted a decline in 
lactate and pyruvate levels over the duration of the study and 
concluded that oxygen therapy apparently increases the oxygen 
available at the peripheral tissues, but increases the work of the 
heart by raising peripheral resistance. However, the recorded 
lactate levels were low and even the highest mean level which 
occurred in the patients with low outputs (mean lactate 1.376 m.M. /L 
blood water, mean pyruvate 0.118 m.M. /L. blood water) was not 
significantly greater than the values obtained in the normal subject 
Significant lactic acidaemia could not be said to be present in any 
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of their patients. It is of interest that while the central venous 
pressure was higher in the patients than in the normal subjects, the 
patients with the lower cardiac outputs had significantly lower 
central venous pressures than did patients with the higher cardiac 
outputs. 
There were further circulatory studies in shock complicating 
acute myocardial infarction by Gunnar, Cruz, Boswell, Co, Pietras 
and Tobin (1966) who studied 23 patients, 12 of whom were shocked. 
The clinical criteria for shock were well defined and similar to 
those used by MacKenzie et al. (1964). They confirmed the findings 
of a low cardiac output in cardiogenic shock and showed that 
peripheral vascular resistance could be either high or low. 
Examination of their data suggests that this finding is entirely 
explicable on their differing cardiac outputs as there was little 
difference in arterial pressure in all patients. They found that 
peripheral resistance could be increased in most patients by 
vasopressor therapy, but that cardiac output then fell. In 2 
patients systemic vascular resistance was not increased by vaso- 
pressor therapy and they postulated that these 2 patients had 
vasomotor unresponsiveness, perhaps due to acidosis, but made no 
measurement of the acid -base status of their patients. 
In a study from McGill University, Smith, Oriol, Morch and 
McGregor (1967) studied the effects of treatment with isoproterenol 
(isoprenaline) and metaraminol in 14 patients with shock complicating 
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acute myocardial infarction. They documented normal values for 
peripheral resistance and interpreted their findings as reflecting 
acute heart failure, in association with a peripheral vascular 
response that was inadequate to maintain normal blood pressure 
(Table II). Isoproterenol caused a decrease in venous pressure and 
an increase in cardiac output, this usually caused an increase in 
blood pressure but in a few patients the inotropic effects of the 
drug were less than its peripheral action and caused a fall in blood 
pressure. Metaraminol caused elevation of blood pressure at the 
expense of a fall in cardiac output. Comment about the acid -base 
status of their patients is pertinent. They measured pH in 9 of 
their 14 patients and this was greater than 7.37 in 4 of these 9 
patients. A summary of their haemodynamic data and the data of Gunna 
and colleagues is presented in Table II. 
In calculating systemic vascular resistance, MacKenzie and 
colleagues had incorporated an allowance for central venous pressure 
giving the so- called driving pressure. 
Thus: 
SVR = Mean Aortic Pressure - Central Venous Pressure x 0.7994 
Cardiac Index 
dynes.sec.cm-5m2 
A similar equation was used by Gunnar's group and in the study by 
Smith and his colleagues. Resistance is the pressure drop (P1 -P2) 
along the segment related to volume flow and as such venous pressure 
can be equated with P2. This is valid if the system behaves as a 
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rigid tube and then resistance would be proportional to flow. In 
living elastic vessels, the relationship is only approximate. A 
certain threshold pressure is required to start flow, which then 
increases rapidly as the vessel expands, finally the vessel resists 
further stretching and increase in flow levels off with further 
increase in pressure (Kitchin and Julian 1968). The threshold value 
of pressure below which flow stops is the critical closing pressure. 
Weil and Shubin (1968) emphasised the importance d this critical 
closing pressure (Clp) in the calculation of peripheral resistance 
as there is no arterial flow until this closing pressure is exceeded 
and suggested that the equation for resistance would be more 
properly rewritten: 
Resistance - 
Pressure - Clp 
Flow 
However, once critical closing pressures have been exceeded, the 
relationship pressure to flow does become approximately linear. 
Absolute values of critical closing pressures are not known although 
typical values would be between 25 and 40 mm Hg (Burton, 1954, Burton 
1965). Permutt and Riley (1963) have presented a detailed theoretica 
analysis of critical closing pressure in relation to vascular tone. 
There are further problems in the interpretation of calculated 
systemicvascular resistance; changes in the ratio of pressure to flow 
are not necessarily attributed to changes in arterial tone, nor does 
such a ratio provide information about changes in regional vascular 
beds. In addition, the numerical value for resistance is no better 
than the measurements on which it is made. 
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The McGill group (Smith et al. 1967 and Sekelj and Oriol 1967) 
have pointed out difficulties in the interpretation of dye dilution 
curves in low output states. The precise point of recirculation is 
difficult to define in the long drawn -out dilution curves. The 
Hamilton technique may be in error if recirculation occurs early in 
the downslope. Smith et al. (1967) advocated use of the Dow formula 
which is based on measurement of the forward area of the curve only, 
but this method is in general less accurate than the Hamilton 
technique and even the Dow formula could be in error in very low 
output states if recirculation occurred on the upslope. Some of 
these difficulties can be overcome by central injection but it is 
likely that alternative techniques such as thermal dilution, in 
which recirculation is unimportant, will prove more useful in the 
study and management of low output states. 
Measurements of pressure are less likely to be in error. 
However, measurement from differing sites such as aorta and radial 
artery will cause variation in pressures obtained (McDonald 1960). 
Because of these considerations, systemic vascular resistance 
is best regarded as a simple ratio and precise interpretations from 
this ratio should be made with caution. 
In an attempt to find either a single factor or a number of 
factors which might be combined and considered as a single index to 
quantitate the patient's conditions Shubin, Afifi, Rand and Weil 
(1968) examined a number of haemodynamic features in 20 patients 
24 
whdmthey described as having the "unequivocal clinical 
manifestations of shock ". They carried out a detailed haemodynamic 
study in patients with acute myocardial infarction and correlated 
their findings in those patients who survived (6) and those who 
died (14). The relative importance of individual and groups of 
haemodynamic parameters was assessed using discriminate function 
analysis. They found individual measurements of stroke index or 
cardiac index were more reliable than measurements of blood 
pressure as indicators of survival. The discriminant function or 
its equivalent, the probability of survival, served as an indicator 
of the severity of shock. Although they made no measurements of 
acid -base status or hypoxia, they suggested that such measurements 
could be incorporated into the discriminant function analysis and 
provide greater information and accuracy. They also pointed out 
that this technique might provide an objective basis for assessing 
the effectiveness of drug therapy. Their results are summarised 
in Table 1.4 group IIIa represent the survivors, IIIb the non - 
survivors. 
Most studies then have shown low cardiac outputs and high 
venous pressures in cardiogenic shock and it seemed likely that 
patients with shock represented the far end of a spectrum of left 
ventricular failure as a response to infarction. The disturbances 
in pulmonary function were in keeping with this hypothesis. 
Doubt on this was again cast by the clinical reports of 
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Nixon and his colleagues (1966, 1967 and 1968 a, b, c) demonstrating 
that patients with cardiogenic shock could be improved by infusion 
of dextrose. Moreover they made direct measurements of left atrial 
pressure in 1 patient and showed this to be normal (Nixon, Taylor 
and Morton, 1968). That volume depletion existed in cardiogenic 
shock was also suggested by Swan, Danzig, Sukumalchantra and 
Allen (1969) who treated 32 patients with volume expansion, 12 of 
whom had a favourable response as judged by an increase in urine 
flow and blood pressure. No haemodynamic studies were performed 
and no details of their patients were published. The same group 
had communicated this information in abstract form previously ( Aller. 
Danzig and Swan, 1967, Allen, Danzig and Swan, 1968). 
Loeb, Pietras, Tobin and Gunnar (1969) reported a more 
detailed study in which they treated 12 patients with the clinical 
features of shock following acute myocardial infarction with low 
molecular weight dextran (LMWD) used as a plasma expander. In 10 
of the patients, central venous pressure was less than 7 mmHg 
(zero reference point not stated). In the remaining 2 patients, 
central venous pressure was 10.5 and 12 mmHg. These 2 patients 
did not respond to LMWD. They divided the remainder of their 
patients into 2 groups depending on their response to LMWD. 5 
patients showed marked clinical improvement and increased urine 
flow after volume expansion. These patients all survived their 
illness. A study of their haemodynamic status prior to therapy 
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shows that this group had a mean arterial pressure of 68 + 10 mmHg 
whilst the non - survivors had a mean arterial pressure of 78 + 15 
mm Hg. Cardiac index also showed considerable difference, the 
surviving group had a mean cardiac index of 2.9 + 0.8 l.min.m2 
whilst the non - survivors had a mean cardiac index of 2.2 + 0.8. 
The cardiac index was increased in both groups after treatment with 
low molecular weight dextran but the high values of cardiac outputs 
and the absence of other haemodynamic and metabolic data must cast 
doubt on the clinical classification of the patients. 
Clarke, Deegan and McKendridc(1968) had reported to the 
British Cardiac Society a study of blood volume changes in acute 
myocardial infarction. They used 
131I 
labelled albumLn as an 
indicator. Patients with uncomplicated infarction showed a slightl 
reduced blood volume. Blood volume was increased in left ventric- 
ular failure, but in 3 patients with shock the blood volume was 
considerably reduced. The principle of blood volume measurements 
is to label a sample of plasma or red cells with a distinctive 
measurable substance. After an adequate time to ensure adequate 
mixing the extent of dilution is taken to represent the volume of 
plasma or red cells (Lewis and Szur, 1967). However, if there is 
inadequate mixing time or there is peripheral pooling of blood, 
conditions very likely to occur in shock, then the dilution will 
be unrepresentative and will lead to erroneous estimates of blood 
volume. 
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Kirby, McNicol and Tattersfield (1968) reported haemodynamic 
findings including left ventricular pressure in two patients with 
severe myocardial infarction with some of the clinical features 
of shock. One patient had a normal cardiac output with a right 
atrial pressure of 12 mm. Hg and a mean pulmonary arterial pressure 
of 31 mm Hg. In this patient, left ventricular end -diatolic 
pressure was 23 mm Hg. This patient had a pH of 7.44 and a plasma - 
bicarbonate of 26 mequiv.litre. The second patient had a metabolic 
acidosis (pH 7.37, plasma- bicarbonate 13.5 mequiv.litre) and a low 
cardiac output; right atrial pressure was 17 mm. Hg, right 
ventricular pressure 39 mm Hg systolic, 17 mm Hg end -diatolic and 
left ventricular end -diastolic pressure 33 mm Hg. In these 2 
patients then there was unequivocal evidence of left ventricular 
failure and no suggestion of volume depletion. 
Cohn, Khatri and Hamosh (1969) reported in abstract form 
measurement of left ventricular end -diastolic pressure (LVIDP) in 
patients with shock complicating acute myocardial infarction and 
noted that LVIDP was raised in all patients even when right atrial 
pressure was normal. No further details were given. 
Russel, Rackley, Pombo, Hunt and Dodge (1969) also reported 
in abstract form measurement of left ventricular pressures in acute 
myocardial infarction. No mention was made of the clinical state 
of the patients. Left ventricular filling pressure ranged from 3 
to 22 mmHg. They infused low molecular weight dextran and studied 
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the changes in stroke volume. They increased left ventricular 
filling pressures from 9 to 36 mm Hg, but stroke volume only 
increased with pressure increments up to 20 mm Hg. They concluded 
that one could expect little increase in cardiac output by elevating 
filling pressures above 20 mm Hg. In the absence of clinical data 
about patient selection these studies do not provide further 
information about the presence or absence of volume depletion in 
cardiogenic shock. 
If volume depletion played a significant role in cardiogenic 
shock, it might be expected that post -mortem studies would reveal 
a number of patients dying with relatively small infarcts. This was 
implied by Nixon, Ikram and Morton (1966) and had been the subject 
of a study by Kurland, Weingarten and Pitt (1965). They studied 
the post -mortem and clinical data of 127 patients dying of acute 
myocardial infarction and tried to correlate the relationship 
between primary branch occlusions and cardiogenic shock. The 
relative frequency of shock was significantly greater in patients 
with branch occlusions, and branch occlusions were associated with 
extensive infarction. It is interesting to note that although 
massive infarction was common in the shock group, an equal number 
of patients who were not graded as shocked were found to have 
extensive infarction. Conversely not all patients with cardiogenic 
shock had extensive infarction. 
Estimations about the size of the infarcted area are 
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difficult to interpret. Unequivocal gross changes do not 
become apparent for some 24 to 48 hours following occlusion of a 
major coronary artery in man, although minimal microscopic 
evidence of infarction amy be recognised as early as 6 hours in 
man (Mallory, White and Salcedo- Salgar, 1939). Nachlas and 
Shnitka (1963) developed a technique for macroscopic identification 
of infarction based on alterations of dehydrogenase activity in the 
myocardium. Their technique involved staining the myocardium with 
Nitro-BT / 2, 2 di-nitrophenyl, 5, 5, diphenyl 3, 3 (3, 3 dimethoxy 
4, 4 biphenylene) ditetrazolium chloride). This substance utilise 
a general dehydrogenase reaction. In the viable muscle where 
endogenous substances, co- enzymes and dehydrogenases are present, 
reduction of Nitro -BT yields a dark blue formazan; necrotic muscle 
fibres remain unstained. Bouch and Montgomery (1970) utilised 
this technique to examine 100 consecutive autopsies from the 
Coronary Care Unit of the Royal Infirmary, Edinburgh. Their 
findings showed that when sensitive techniques were used the 
infarcted area was always large in cardiogenic shock. The 
pathological findings do not yet allow interpretation of the preci 
sequence of events; early shock might occur with a small infarct, 
and prolonged hypotension and inadequate coronary perfusion might 
lead to more extensive infarction. Further developments in 
pathological and clinical techniques are required to determine the 
sequence of events following infarction. 
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If there is not a significant hypovolaemia in cardiogenic 
shock the finding of a low stroke volume would argue that there is 
severe impairment of the left ventricle. Ross (1967) suggested 
another possibility that asynergy or asynchrony of the left 
ventricle may be a major feature of cardiogenic shock. This 
argument was used by Nixon, Ikram and Morton (1966), when they 
first reported their successful use of volume expansion. In 2 
of their patients there was a high central venous pressure and 
further elevation was brought about by the infusion of 5% 
laevulose, and at the same time there was an improvement in both 
patients' clinical condition. They suggested that after 
infarction an increased left ventricular volume decreased cardiac 
asynergy and improved left ventricular function. 
In this thesis only changes that may occur in the 
circulation when the patient is in sinus rhythm have been 
considered. This has been done because although the clinical 
features of cardiogenic shock may occur in patients with 
arrhythmias, correction of the arrhythmias usually reverses the 
shock syndrome. However, not all patients will be improved. We 
have reported (Lassers, Anderton, George, Muir and Julian, 1968) 
a study of the haemodynamic effects of pacing in complete heart 
block complicating acute myocardial infarction. Whilst pacing 
increased cardiac output in most patients, stroke volume fell as 
the heart rate increased, indicating myocardial performance was 
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abnormal. In 3 patients there was no increase in cardiac output with 
artificial pacing. These 3 patients all exhibited the features of 
cardiogenic shock both before and after pacing. Future studies on 
shock complicating myocardial infarction could include patients with 
heart block provided it had been demonstrated that there wàs no 
improvement after an adequate trial of pacing. Similarly, patients 
who have had other arrhythmias and have been returned to sinus 
rhythm but still continue to demonstrate the clinical features of 
shock could also be included. 
In summary although most careful circulatory studies have 
shown left ventricular failure in cardiogenic shock,there exists a 
number of reports casting doubts on these findings. Cardïogenic 
shock may not be a unitary concept and there may be differing 
circulatory states masquerading under one clinical guise. One of 
the main difficulties in interpreting many of the studies in acute 
myocardial infarction is the difficulty in clinical definition. That 
clinical classification alone is inadequate, is demonstrated by the 
wide disparity in reported cardio- respiratory findings in patients 
who are severely ill following acute myocardial infarction. It is 
important to try to find an objective definition or definitions to 
categorise the patients and allow an adequate evaluation of various 
therapeutic regimes. Moreover it is only by an understanding of the 
abnormal physiology in the severe grades of myocardial infarction 





One of the major advances in the management of the severely 
ill patient is the introduction of various bedside monitoring 
techniques. The value of E.C.G. monitoring for the detection and 
treatment of arrhythmias has been demonstrated (Lawrie et al. 1967). 
In the investigation and treatment of patients who have hypotension 
and low cardiac outputs,facilities which allow measurement of 
pressure and flow are of great value. In 1965 MacKenzie described 
the provision of a specially equipped room attached to a general 
medical ward so that such measurements could be made. 
Many of the studies described in this thesis were conducted 
in this intensive care room, but continuing work in the management 
of acute myocardial infarction and in other areas of intensive care, 
have revealed the need for more mobile equipment. The equipment 
can then be taken to the patient rather than the patient moved to 
the special investigational area. 
During these studies the equipment has undergone 
considerable modification but the essential features have been: 
1. Pressure recording facilities with transducers, 
amplifiers and portable recording facilities. 
2. Cuvette densitometer assembly with output to the 
33 
recorder for the measurement of cardiac output. 
3. Facilities for rapid injection of dye and constant 
withdrawal pump. 
4. Electro- cardiogram with output to recorder and separate 
output to oscilloscope to provide continuous patient 
monitoring. 
This equipment can now be mounted on one single trolley and can 
be taken to the bedside of a patient who is seriously ill. This allo 
better patient monitoring and the circulatory observations provide 
information for a more rational therapeutic policy in the management 
of the individual patient. 
PRESSURE RECORDING 
1. Catheter Technique: 
Systemic Arterial Pressure was obtained using a small bore nylon 
catheter (Portex O.D. 1.34 mm. length 30 cm). This was introduced 
percutaneously into the brachial artery using a modified Seldinger 
technique. In 2 patients with cardiogenic shock the brachial artery 
was not palpable, and the femoral artery was catheterised. 
Right Atrial or Central Venous Pressure was obtained by 
advancing a no. 7 double lumen Cournand catheter from an antecubital 
vein. The position of the catheters was judged to be adequate, 
when there was a good respiratory movement on the pressure 
recording. 
Right Ventricular and Pulmonary Arterial Pressure was obtained 
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by various modifications of the technique described by Bradley (1964) 
In this technique a small polyethylene catheter is allowed to 
'float' into the pulmonary artery. The position is judged by the 
pressure wave form obtained. The technique demands a compromise 
between small catheters which enter the pulmonary artery easily 
and larger versions which allow adequate pressure recordings and 
blood sampling. Most of the studies were performed with a 
Portex O.D. 0.75 mm. catheter but the Phillips pulmonary catheter 
6.113.09 has proved even easier to use in more recent studies, 
providing a better pressure wave form and allowing easier sampling 
of mixed venous blood. 
2. Recording System: 
Zero reference point was 5 cm. below the sternal angle. 
All pressures were transduced using a Statham P23 Db strain 
gauge manometer. Appropriate calibration values were obtained from 
an open saline column, aneroid manometers or mercury column 
manometers. 
The pressures were recorded on a Honeywell U.V. recorder 
or in special circumstances a Rikadenki 3 pen recorder . 
3. Frequency Response: 
The measurement of systolic and diastolic pressure peaks 
*Honeywell Controls 
+ Rikadenki Kogyo 
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requires a catheter system of relatively low frequency response 
(6 cycles /second). To record mean pressures the recording system 
can have a very low frequency response. However, the frequency 
response of micro catheter systems is not known and to determine 
the dynamic frequency response of our own system a series of studies 
were carried out. 
The method was a modification of the technique described by 
Fry (1960). A hole was bored in the barrel of a 20 ml syringe, 
by blocking the hole with a damp finger and pressing the plunger, a 
pressure is generated. If the finger is quickly released the drop 
in pressure produces a square wave. A square wave transmitted 
through the complete recording system (i.e. catheter, transducer, 
amplifier and recorder) allows a check on the dynamic frequency 
response. 
The square wave is recorded with an overshoot. The overshoot 
is used to obtain a damping ratio k.. 
1 1 
Where the quantity t-1 is the natural logarithm ratio of the 
amplitudes of any two successive excursions in the oscillatory 
transient response to the stepwise change in pressure. 
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Knowing h, the undamped natural frequency J. can be computed 
(,)v 
/_ 
` radians /sec . or cycles /sec. 
f)cl,_ is the damped natural frequency, this is calculated from 
the frequency of after vibrations of the transient response to the 
square wave. The dynamic frequency of whole system i.e. the Portex 
O.D. 0.75 mm. catheter, Statham transducer amplifier and U.V. 
recording system was 15.49 + 4.32 cycles /sec. Where the Rikadenki 
pen recorder was used the system was limited by the frequency 
response of the pen recorder which was 6 cycles /sec. Small air 
bubbles caused marked damping and the frequency response of these 
micro catheters was markedly improved by a period of continuous 
flushing. 
CARDIAC OUTPUT DETERMINIATIONS 
In the present studies cardiac output was determined by the 
dye dilution technique using indocyanine green as an indicator. 
This method was first described by Stewart in 1897. 
The introduction of better indicators and accurate quick 
reading densitometers has allowed development of the original 
technique. Details of the method used in the Department of Medicine 
the University of Edinburgh, have been described by MacKenzie (1965) 
and Sapru (1966). The essential features and later modifications in 
technique are outlined below. 
General Principles: A small accurately known amount of indicator 
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is injected into the right side of the circulation. Its subsequent 
dilution is proportional to the flow of blood. By sampling blood 
from the left side of the circulation and recording the dilution 
curve produced, an estimate of the cardiac output can be made. 
Dye Injection: Approximately 2 ml of indocyanine green was injected 
rapidly by allowing compressed air to drive close the plunger of a 
specially made syringe. This was automatically reloaded after each 
injection from a reservoir. The activation of the syringe controlled 
a 3 way tap to allow injection to the patient and re- filling from 
the reservoir. 
The syringe was made so that a fixed volume was delivered at 
each injection. At the end of each study, the actual injected 
volume was determined by weighing 4 flasks before and after a bolus 
injection. The injected volume varied from study to study but in 
any one patient never varied by more than 0.01 ml. 
Dye Dilution Sampling: Immediately before the injection of the dye, 
arterial blood was withdrawn from the arterial line through a cuvette 
and this sampling continued until the dye dilution curve had been 
completed. A constant withdrawal rate was maintained throughout the 
sampling period by using the Harvard constant infusion -withdrawal 
pump (Harvard Apparatus Co. Inc.) and using 50 ml Luer -Lock syringes. 
The cuvette densitometer was the Waters x 300 system. This consists 
of a cuvette with two cadmium selenium photocells, one with maximum 
sensitivity at 800 Á, the wave length of indocyanine green dye, 
while the other cell gave minimal transmission at this wave length. 
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The passage of dye through the cuvette creates an imbalance in the 
cuvette which is part of a Wheatstone bridge. The resultant signal 
is amplified and the output can be described on any suitable 
recorder. 
Measurement of Dye Curves: In an ideal system there is no 
recirculation and a bolus injection produces a curve which rises 
rapidly to a peak and then decays in exponential fashion. Cardiac 
output is inversely proportional to the area under the curve. In 
man recirculation occurs so that only the early part of the decay 
curve is exponential. Recirculation can be accounted for if the 
exponential part of the decay is extrapolated to zero and the area 
under this curve measured (Hamilton, Moore, Kinsman and Spurling, 
1932, Zierler, 1962). 
Method of Calibration: Calibration involved a whole blood 
technique, 40 ml of blood was removed from the patient at the end 
of the study. This was placed 4:n a siliconised flask containing a 
small amount of heparin (0.5 ml of 25,000 units.ml heparin with 
chlorocresol preservative). After thorough mixing the actual 
calibration was carried out. 
Using a micro -pipette (Micro -Repette, Gencons) a small 
volume of dye was injected into a 10 ml flask. This micro syringe 
is capable of delivering 10 micro litres to an accuracy of + 1.5 %. 
Double and treble the dye volume was injected into two further 
10 ml flasks. These flasks were then made up to 10 ml from the 
stored blood. The flasks were sealed and inverted repeatedly to 
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ensure adequate mixing. The remaining 10 ml of blood was used for 
base line control. 
The calibration blood was withdrawn through the cuvette at 
. the same withdrawal rate as that used in the study in ascending 
order of concentration. The average value of the three steps was 
taken as the calibration factor. In other words 10 g litres of dye 
diluted in 10 ml of blood produced a calibration step of x cros. 
These factors were then used in the equation: 
Cardiac output 1 /min 
Where 1 is dye injectate volume 
60 x I 
-"c x F i 
c is sum of heights of dye curve at second 
intervals measured in centimetres. 
F is calibration factor in ml.cm. 
BLOOD GAS TENSIONS AND pH. 
These were measured on an Instrumentation Laboratories Inc. 
type 113 -SI ultra -micro pH and blood gas system. The accuracy of 
this instrument in our laboratory has been described (Flenley, 
Millar and Rees, 1967). 
Oxygen tensions were measured using a Clark polarographic 
electrode. A polarising voltage is applied which reduces oxygen 
diffusing through a gas -permeable membrane. This reduction 
produces a flow of electrons and it is this current which is 
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measured. The electrode was calibrated using "white spot" nitrogen 
as zero reference and humidified air as the high reference point. 
Where the high scale was used, humidified oxygen was used as the 
high reference point. 
Carbon dioxide tensions were measured using a Severinghaus type 
electrode which measures change in pH in a electrolyte solution due 
to diffusion of CO2 through a gas -permeable membrane. This 
electrode was calibrated using CO2 mixtures of approximately 3 
and 10 %. The precise levels were determined by Lloyd Haldane 
analysis of the gas mixtures. 
pH was measured using a glass electrode and calomel reference 
electrode. The electrode was calibrated using precision buffers of 
6.81 and 7.383 (Radiometer Copenhagen). 
All readings were made at 37 °C. With this system duplicate 
analysis can be performed on sample volumes of 2 ml. 
OXYGEN SATURATION AIGU) OXYGEN CARRYING CAPACITY 
Oxygen Saturation: Oxygen saturation was measured directly and also 
derived from the oxygen tension. The direct method was the haemo- 
reflector method described by Zijlstra (1957). Although this 
technique is widely used there are a number of disadvantages. As 
oxygen saturations falls the haemoreflector method becomes less 
accurate (Cole and Hawkins, 1967). Variations in haemoglobin 
concentration will also introduce errors as the technique depends on 
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light reflection (Zijlstra 1957). The sample volume required is 
approximately 5 mi. Using the 'float -in' catheter to enter 
pulmonary artery samples as large as this are difficult to obtain. 
Thus arterial oxygen saturation was measured directly whilst venous 
oxygen saturation was derived from measured oxygen tension and pH 
using the data of Severinghaus (1966). This method is open to 
criticism as well. The conversion to oxygen saturation is made on 
the steep portion of the haemoglobin dissociation curve and small 
errors in measurement of oxygen tension could be magnified on 
conversion to saturation; thus a 1 mm error in oxygen tension will 
lead to a 3% error in venous oxygen saturation. Moreover, it is 
possible that all patients do not have the same haemoglobin 
dissociation curves (Metcalfe, Dhindsa, Edwards and Mourdjinis (1969 
Despite these technical considerations, the measurement of oxygen 
tension and conversion to saturation is adequate for clinical 
purposes. Ideally total oxygen content should be measured but the 
sample volume required for the standard method is large and 
difficult to obtain through a float catheter. Micro -method for the 
measurement of total oxygen content are available and are likely to 
be improved (Linden, Ledsome and Norman, 1965). 
Oxygen Carrying Capacity: This was measured by light transmission 
using a spectrophotometer (Unlearn Instruments Ltd. SP600). This 
method was standarised against the Van Slyke manometric method 
(Staunton, 1966). 
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MEASUREMENTS AND CALCULATIONS 
Pressure and Flow: 
Intravascular pressures and heart rate were measured as the 
average of 15 second values falling about the definitive point. 
Mean pressures were obtained by electronic damping. Cardiac output 
determinations, measured by the techniques described earlier, were 
made at 5 minute intervals. Results were corrected for body surface 
area. In the presentation of haemodynamic variables in chapter III 
the values given are the average of at least 4 determinations. 
Systemic vascular resistance was calculated according to the 
formula. 
Mean Aortic Pressure x 1332 x 60 
Systemic Vascular Resistance - 
-5 2 Cardiac Index 
(dynes.sec.cm m ) 
Stroke volume was obtained by dividing the cardiac index by 
the heart rate. 
Gas Exchange: 
Temperature correction and derivation of oxygen saturations 
were made on the calculator described by Severinghaus (1966). 
As estimate of alveolar oxygen tension (PAO2) was made using 
the formula derived from Riley, Cournand and Donald (1951). 
PAO2 = PIO2 - 





where PIO2 is the inspired oxygen tension. 
FI02 is the fraction of oxygen in the inspired gas. 
PaCO2 is the arterial carbon dioxide tension. 
Gas collections were not made routinely; the respiratory exchange 
rate was assumed to be 0.80. The derived alveolar oxygen tension 
was used to calculate the oxygen content of end -pulmonary capillary 
blood. The difference between alveolar and arterial oxygen tensions 
is expressed as the alveolar to arterial difference (A- aD02). The 
main components of this difference or gradient result from 
(a) a component of venous admixture due to scatter of 
ventilation: perfusion ratios in different parts 
of the lung. 
(b) shunted unoxygenated venous blood which mingles 
with oxygenated blood leaving the pulmonary capillaries. 
The contribution made by ventilation: perfusion ratios may be 
estimated using the equation 
Qva 
CO2 - Ca02 
Qt C602 - Cv02 
where Qva is the venous admixture. 
Qt is the total blood flow. 
CO 
2 
is the oxygen content of end -pulmonary 
capillary blood. 
CaO2 is the oxygen content of arterial blood. 
Cv02 is the oxygen content of mixed venous blood. 
After the patient has inspired a high level of oxygen for 
20 to 30 minutes, it is assumed that all alveoli are fully oxygenated 
and that blood leaving these alveoli should be fully saturated. Any 
arterial hypoxia then occurring can be attributed to perfusion of 
non -functioning gas exchanging units. This has been called the 
"true shunt" and is calculated as 
Qs = Cé0 - Cv0 
2 Qt 2 
where Qs is the "true shunt" 
CcO2 - CaO2 
This equation assumes that all shunted blood is mixed venous 
and no allowance is made for shunting occurring in the Thebesian 
and bronchial veins. 
In the calculation of oxygen content at high levels of 
inspired oxygen it is important to include the amount of dissolved 
oxygen in the plasma. 
PATIENT SELECTION 
Individual details of patients are documented in relevant 
sections. Myocardial infarction was diagnosed using the criteria 
of the World Health Organisation (1959). They suggested that 
patients could be classified as 
A "Very probable" myocardial infarction if they satisfied the 
following criteria: 
45 
a) Association of Q,I not less than 20% of R,I and negative 
T,I (a sign of anterolateral infarction has to be 
confirmed by precordial leads). 
b) Association of Q,II and negative T,II, Q,II and negative 
T,III and QVF. Q at least 25% of the largest R wave 
in III and not less than 0.03 sec. in II and III. 
c) Q waves in precordial leads V1, V2, V3 and negative 
or diphasic T waves in V2 and V3 (QRS not exceeding 
0.10 sec.). When no R wave present = QS configuration). 
d) Q waves more than 0.4 mV in precordial leads V4 and 
V5 or 0.2 mV in V6 in association with negative T 
waves in these leads. 
e) Injury current - evolution and disappearance in three 
stages. 
B "Possible" myocardial infarction: 
With changes in ST segment T wave changes suggestive of 
infarction accompanied by a rise in serum enzymes. 
Of the 70 patients studied and presented in this thesis, 
59 fulfilled the criteria for diagnosis as "very probable myocardial 
infarction ". 11 were "possible" myocardial infarctions. In these 
patients, serum enzymes were elevated, the serum creatinine kinase 
> 80 i.u. or serum aspartate aminotransferase (SGOT) > 50 Reitman 
and Frankel units. 
An approximate estimate of the severity of the infarct was 
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made by classifying the patients as (1) uncomplicated, (2) with 
left ventricular failure, (3) with cardiogenic shock. The 
uncomplicated cases were those who exhibited no evidence of shock 
or left ventricular failure. Left ventricular failure was judged 
to be present when there was widespread lung crepitations and 
dyspnoea, in the absence of a history of bronchitis. Cardiogenic 
shock was diagnosed when there was pallor, cold skin, restlessness 
and oliguria with a systolic blood pressure remaining below 100 
mm Hg measured by sphygmomanometry. In addition these patients were 
without marked dyspnoea. All the patients were in normal rhythm 
and there was no improvement in the shock state half an hour after 
the relief of pain and administration of oxygen. This classification 
is similar to that used by Freis et al. (1952) and MacKenzie (1965). 
CARDIO- RESPIRATORY STUDIES IN ACUTE MYOCARDIAL INFARCTION 
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CHAPTER III 
CARDIO -RESPIRATORY STUDIES IN ACUTE MYOCARDIAL INFARCTION 
RESULTS: 
A Clinical Status 
The patients were grouped into 3 broad clinical groups defined 
in Chapter II. The clinical features of each patient was recorded 
prior to investigation. There were 26 patients with uncomplicated 
myocardial infarction and a summary of the clinical features in 
these patients is shown in Table 3. These patients were studied 
during investigations into the action of opiates in acute myocardial 
infarction. For this reason it was important that no patient had 
received drug therapy within 12 hours of the investigations, thus 
some of the patients were not studied immediately after admission, 
but all patients were studied within 36 hours of infarction. In the 
groups with left ventricular failure or shock, such a drug free 
period could not be obtained and these patients were investigated 
shortly after admission to hospital. No patients had pressor 
therapy prior to the investigation. There were 10 patients in the 
group with left ventricular failure (Table 4). In the group with 
shock there were 7 patients (Table 5). One of these patients,TA, 
survived the shock state, but on the following day developed severe 
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left ventricular failure. This patient was studied twice and the 
clinical features whilst shocked and whilst in left ventricular 
failure are shown in the appropriate tables. 
Chest x -rays were interpreted according to the criteria of 
Steiner (1969). They were defined as abnormal if they showed: 
1. Pulmonary venous distension or congestion in the 
upper zones indicating reversal of blood flow and 
differential vasoconstriction. 
2. Pulmonary oedema: no distinction was made between 
intra- alveolar pulmonary oedema (batswing) and 
interstitial pulmonary oedema (septal lines). 
A summary of the autopsy findings is shown in Table 6. In 4 of the 
7 autopsies there was evidence of old ischaemic damage to the 
ventricle. In all but one autopsy the recent damage, as demonstrated 
by the Nitro BT stain, was very extensive. In patient TA who had 
survived the shock state and developed left ventricular failure 
and had died later from a cerebral embolism, there was only a small 
area of ischaemic damage on the anterior border of the left heart. 
B Cardio -Respiratory Status 
The observations in patients with uncomplicated myocardial 
infarction and left ventricular failure were made whilst breathing 
room air. In the group with shock, only initial blood gas tensions 
were obtained whilst the patients were breathing air, all other 
observations were made whilst the patients were breathing high flow 
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oxygen through a polymask (B.O.C.). Our own observations suggests 
that with this mask and oxygen flow rates over 10 litres min, the 
patient is breathing approximately 65% oxygen. 
Cardio- respiratory measurements of the uncomplicated group 
(group I) are given in Table 77of the group with left ventricular 
failure (group II ) in Table 8 and of those with shock (group III) 
in Table 9. Where the data is presented in diagramatic form, the 
data of MacKenzie (1965) is also shown. 
Arterial Pressure: The systolic arterial pressure in patients with 
uncomplicated myocardial infarction ranged from 101 to 233 mm Hg 
(mean 136 S.E.M. + 6.54 mm Hg) whilst in those patients with left 
ventricular failure from 80 to 156 mm Hg (mean 116 + 8.57 mm Hg). 
In the patients with shock, systolic arterial pressure ranged from 
52 to 112 mm Hg (mean 71 + 7.96 mm Hg) (fig. 1). When the groups 
are compared using a non -paired 't' test the t value for group I 
compared with group II is 1.69 > 0.05. However, systolic blood 
pressure was significantly lower in the group with cardiogenic 
shock (t 3.67, 0.001 < p < 0.005). 
In 3 of the 'shocked' patients, blood pressure could not be 
obtained by conventional sphygmomanometry whilst in the other 
patients with shock cuff blood pressure readings bore little relation 
to intra- arterial pressure. Patient Al had a systolic blood pressure) 
of 75 mm Hg by sphygmomanometry but the recorded intra- arterial 







































MEAN & S. D. 
O M ° KENZIE (1965) 
Fig. 1 
Systolic arterial blood pressure in acute myocardial 
infarction. The standard deviation is drawn on the data presented 
in this chapter. In addition the individual values obtained by 
MacKenzie (1965) are plotted (2) but are not included in the 
calculation of the standard deviation. 
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Mean arterial pressure (fig. 2) for group I ranged from 56 
to 164 mm Hg (mean 101 + 4,48 mm Hg); in group II the range was from 
60 to 125 mm Hg (mean 83 + 7.17 mm Hg); in group III mean arterial 
pressure ranged from 40 to 94 mm Hg (mean 56 + 7.08 mm Hg). The 
more severely ill patients had the greater reduction in mean 
arterial pressure (I:II t 2.11, 0.025 < 0.05; II :III 2.68, 0.01 < 
p < 0.02). 
There was a less marked difference in diastolic blood 
pressure in the more severely ill. The mean diastolic pressure was 
78 + 3.69 mm Hg in group I, in group II 66 + 5.86 mm Hg and in 
group III 47 + 6.78 mm Hg. Because of the wide range of recordings 
the differences between groups I :II and II :III were not statistically 
significant, although group III was significantly lower than group 
T (t 4.62, p < 0.001). 
Cardiac Output; The mean output corrected for body surface area 
was 2.71 + 0.075 litres.min.m2 in the uncomplicated group. Cardiac 
index ranged from 1.96 to 3.39 litres.min.m2. The cardiac index in 
the group with left ventricular failure was significantly lower 
(mean 2.09 + 0.154 litres.min.m2) (t 4.05, p < 0.001). The cardiac 
index in the shocked group was significantly lower (mean 1.34 + 
0.055 litres.min.m2) than the group with left ventricular failure: 
(t 3.94, 0.01 < p 0.02). Despite the highly significant difference 
between the 3 groups there was an overlap in cardiac output 

































°ó ó  
MEAN & S.D. 
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Fig. 2 
Mean arterial blood pressure in acute myocardial infarction. 
Presentation details are the same as in Fig. 1. 
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having a wide range of values (1.29 - 2.79 litres.min.m 
2 
) (fig. 3). 
There was no such overlap between groups I and III. 
Heart Rate: (fig. 4) There was a wide range of heart rates for 
all groups and although heart rates were usually higher in the 
groups with failure and shock there was no significant difference 
between the groups (I:II t 1.87, p > 0.05, II:III t 0.60, p > 0.05). 
Stroke Volume: (fig. 5) The mean stroke volume (stroke index) for 
group I was 33 + 1.47 ml.m2. This was significantly higher than in 
the group with left ventricular failure (mean 23 + 2.70 ml,m2) 
(t 3.34, 0.001 < p < 0.005). In group III there was a marked 
2 
reduction in the stroke volume with a mean value of 13.5 + 1.13 ml.m 
(group II:III t 2.84 0.01 < p < 0,02). Again there was considerable 
overlap so that some of the patients with left ventricular failure 
had stroke volumes as high as in the uncomplicated group, whilst 
others had markedly reduced stroke volumes and as low as some of 
the patients with cardiogenic shock (fig. 6). 
Systemic Vascular Resistance: The relationship of calculated 
systemic vascular resistance to systemic arterial pressure, cardiac 
output and the gradings of infarction is shown in fig. 7. There was 
no significant difference between the groups (I:II t 0.80, p > 0.05; 
II:III t 0.30, p > 0.05). It is of note that only one patient 
with cardiogenic shock had a calculated systemic vascular resistance 
outside normal limits (Al, 6730 dynes sec cm -5m2). 
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Fig. 3 








































Heart rate in acute myocardial infarction. 
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Fig. 5 
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Fig. 6 
The relationship of cardiac output to heart rate in varying 
degrees of severity of acute myocardial infarction. Isopleths 













ARTERIAL PRESSURE , CARDIAC OUTPUT AND SYSTEMIC VASCULAR RESISTANCE 
UNCOMPLICATED 
o LEFT VENTRICULAR FAILURE 
- o CARDIOGENIC SHOCK o 
I.0 2.0 
CARDIAC INDEX I.min.m 
Fig. 7 
3.0 4.0 
The relationship of cardiac output to mean aortic pressure in 
varying degrees of severity of acute myocardial infarction. Isopleth 
repregent the calculated systemic vascular resistance in dynes sec 
c-5 m m . 
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group I was 3.8 + 0.59 nun Hg. 4 patients in this group had right 
atrial pressures greater than 5 mm Hg. In the group with left 
ventricular failure, the lowest right atrial pressure was 4 nun Hg 
and the mean for the group was 8.3 + 1.04 nun Hg. This was 
significantly greater than the mean pressure for group I (t 3.95, 
p < 0.001) but there was no significant difference between group II 
and group III (t 0.101, p > 0.05). 
Pulmonary Arterial Pressure: (fig. 9) In 3 patients these 
observations were made using a Cournand No. 7 catheter and in these 
patients the pu1monar LLitery wedge pressure is also recorded in 
Table 8. In 33 patients pulmonary artery pressure was measured 
using the flow guided catheter described in chapter II. In 7 
patients no measurement could be made for technical reasons, usually 
due to failure to pass the small catheter up a peripheral vein. 
These findings occurred in the earlier studies and newer catheters 
and mire experience made the passing of this catheter a relatively 
simple technique. There was no serious arrhythmia caused by the 
introduction of this catheter into the pulmonary artery. 
The mean pulmonary arterial pressure in group I was 19 + 
1.56 mm Hg. In one patient (MU) the pulmonary artery pressure was 
markedly elevated at 40 mm Hg. On subsequent review, the chest 
x-ray of this patient showed pulmonary venous congestion. The mean 
pulmonary arterial pressure was significantly greater in group II 
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Mean right atrial pressure in acute myocardial infarction. 
In the report by MacKenzie zero reference point was at the 
sternal angle. For comparison purposes his right atrial pressures 
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MEAN 8 S.D. 
Fig. 9 
Mean pulmonary arterial pressure in acute myocardial infarction. 
(Pulmonary artery pressure was not measured by MacKenzie). 
jJ 
than group I (mean 27.6 + 2.08 mmHg) (I :II t 3.15, 0.001 < p < 
0.005). The mean pulmonary arterial pressure in cardiogenic shock 
was also elevated (mean 28 + 1.84 mm Hg), but this was not 
significantly different from the group with left ventricular 
failure (t 0.02, p > 0.05). The relationship of right atrial 
pressure to pulmonary arterial pressure is shown in fig. 10. 
Arterial Oxygen Tension: (fig. 11) The Pa02 was reduced in all 
groups with the lowest values being found in patients in groups II 
and III. The range of Pa02 for patients with uncomplicated 
myocardial infarction was from 42 to 80 mm Hg (mean 64 + 2.11 mm Hg), 
There was no significant difference between mean Pa02 in group II 
(54 + 3.52 mm Hg) and group III (mean 54 is 6.46 mm Hg) whilst 
breathing air, but whilst breathing > 60% oxygen the patients in 
group II had an increase in Pa02 similar to group I, whilst those 
in group III had only a small rise in Pa02 (fig. 12). There was 
one exception, patient TA, in group II. This patient had severe 
and intractable pulmonary oedema and intermittent positive pressure 
ventilation was instituted. Despite hand ventilation via an 
endotracheal tube with 100% oxygen, the Pa02 was only increased to 
88 mm Hg. In a similar situation in a patient not reported in this 
series, but with cardiogenic shock, intermittent positive pressure 
ventilation with 100% oxygen produced an arterial oxygen tension 
of 320 mmHg. 














r= 0.6359 p<0.001 
n= 36 
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Fig. 10 
The relationship of right atrial pressure to pulmonary arterial 
pressure in acute myocardial infarction. (Regression line calculated 
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Arterial oxygen tension, carbon dioxide tension and hydrogen 
ion concentration in acute myocardial infarction. 



















Response to oxygen therapy (approximately 65% 02) in acute 
myocardial infarction. The non -shock group consists of patients 
from groups 1 and II. 
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dioxide tensions are reduced in left ventricular failure. Although 
several patients with left ventricular failure had a very low PaCO2 
the mean PaCO2 was not significantly different from the other 2 
groups. One of the patients with a high PaCO2 in group II had 
chronic bronchitis and in this patient (FI) a small dose of 
pethidine brought about an even greater increase in carbon dioxide 
tension. The patient made a satisfactory recovery from his infarct 
but his PaCO2 remained elevated after discharge from hospital. 
Arterial pH: The pH values for each group are shown in Tables?, 8 
and 9 and these values have been converted into hydrogen ion 
concentrations for graphical display in fig. 11. The pH was low 
in all patients with cardiogenic shock. In 3 of the patients with 
left ventricular failure, the pH was below 7.40. As a simple 
attempt to describe the acid -base status of the patients the 
standard bicarbonate of each group was calculated. In group I the 
mean standard bicarbonate was 27.0 + 0.71 mequiv. litre, in group 
II, 25.1 + 1.48 mequiv. litre and in group III 16.6 + 1.78 mequiv. 
(I:II t 1.32, p > 0.05) (II:III t 3.67, 0.001 < p < 0.005). 
Mixed Venous Oxygen Saturation (Sv02): (fig. 13) For technical 
reasons this was only obtained in 30 patients. The patients with 
uncomplicated myocardial infarction had a mean Sv02 of 63.6 + 1.70 %. 
In the patients with left ventricular failure SvO2 was significantly 
lower at 46.0 + 3.74 (t 5.287, p < 0.001). The patients with 























Mixed venous oxygen saturations in acute myocardial infarction. 
Patients with shock were breathing oxygen whilst this measurement 
was made. 
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breathing > 60% oxygen whilst Sv02 was measured. In this group the 
mean Sv02 was 40.0 + 3.20 %. The relationship of cardiac index to 
Sv02 is shown in fig. 1.4. 
Arterio- Venous Oxygen Difference: The measured arterio- venous 
oxygen difference in group I ranged from 2.19 to 9.18 vols.% 
(mean 6.22 + 0.467 vols. %). In group II the range was from 4.98 
to 12.6 vols.% (mean 7.87 + 0.796 vols. %) (t 1.92, p > 0.05). Again 
group III were not strictly comparable as they were breathing high 
concentrations of oxygen. In this group the mean arterio -venous 
difference was 9.84 + 1.447 vols. %). 
The patient in group I with the high pulmonary arterial 
pressure (MU) had a low mixed venous oxygen saturation (48 %) and 
the highest arterio -venous oxygen difference measured in group I 
(9.18 vols. %). 
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Cl= 0 04 Sv02+ 0.24 
r = 0.789 
p<0.001 
± 0.41 
10 20 30 40 50 60 70 80 90 
SvOy 
Fig. 14 
The relationship of mixed venous oxygen saturation to cardiac 
output in varying degrees of clinical severity of acute myocardial 
infarction. Each clinical group is represented by the same symbol 
as in the previous diagram. 
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DISCUSSION 
Arterial pressure is a relatively poor guide to the severity 
of infarction for, although systolic arterial pressure was reduced 
in patients with cardiogenic shock, systolic arterial pressure was 
also low in some patients with uncomplicated myocardial infarction 
and left ventricular failure. A low level of blood pressure has 
often been used as an index of the patients' clinical condition and 
as a guide to the necessity for therapeutic support. Thomas, 
Malmcrona and Shillingford (1965) reported on the haemodynamic 
features of 7 patients with hypotension after myocardial infarction. 
Their paper can be criticised on methodological grounds; dye dilution 
curves were determined using a photoelectric ear- piece, despite the 
presence of clinical shock in some of their patients; not all of 
the investigations were performed during the acute stage. However, 
they did demonstrate that cardiac output could be normal or low in 
patients with hypotension. From their data it appeared that low 
blood pressure per se was relatively unimportant in determining the 
clinical course of the patient. However, the measurement of 
intra- arterial pressure is of real value in cardiogenic shock 
because of discrepancies between cuff blood pressure and intra- 
arterial pressure in shock. Intra- arterial pressures provided the 
only accurate means of determining blood pressure in shock and of 
following responses to therapy. In addition mean or diastolic 
pressure recordings are more likely to be of value in low output 
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states as these levels are more important determinants of coronary 
blood flow than is systolic pressure. If some measurement of blood 
flow can also be made then much more precise information about the 
patient's circulatory condition can be given. 
The detailed observations of MacKenzie (1965) had shown 
considerable reduction in cardiac output in those patients with 
cardiogenic shock. There was some reduction in cardiac output in 
patients with uncomplicated myocardial infarction so that to a 
certain extent the two groups overlapped. The stroke volume 
determinations for the two groups showed little overlap and he 
suggested that some of the shocked patients managed to maintain an 
adequate cardiac output by an increase in heart rate. He also noted 
that patients with shock had a high right atrial pressure and a 
normal or raised central blood volume. The low stroke volume without 
signs of hypovolaemia suggested severe impairment of left ventricular 
function in cardiogenic shock. In his study he had made observations 
on only two patients with left ventricular failure but the findings 
in those patients were of reduced cardiac output and stroke volume 
to almost the same extent as in the patients with cardiogenic shock. 
Normal values for cardiac output at rest have been compiled 
by Wade and Bishop (1962). They suggested that values above 4.6 
litres min m2 and below 2.4 litres min m2 were unlikely to be found 
in normal subjects. On this basis, 5 of the patients in the 
uncomplicated group in the current study had a low cardiac output. 
5 ̀; 
Furthermore the majority of the remainder had a cardiac output in 
the low normal range. 8 of the 10 patients with left ventricular 
failure and all the patients with cardiogenic shock had a low cardiac 
output. Indeed in this study there was no overlap between the 
shocked patients and those with uncomplicated myocardial infarction 
and there was a progressive reduction in cardiac output with the 
increasing clinical severity. There was also a similar reduction 
in stroke volume with the increasing clinical severity of the 
infarction. Some of the difficulties inherent in the measurement 
of cardiac output in low output states were mentioned in Chapter I. 
The very slow circulation makes the inscription of the dye curve 
lengthy. Recirculation of dye from such areas as coronary 
circulation may occur relatively early in the dye curve so that 
determinations of the area under the curve are inaccurate. A 
further source of error may be introduced by the correction for body 
surface area; a more accurate standardisation could be achieved by 
correction for lean body mass. Despite these considerations, cardia 
output determinations presented in this chapter show a consistent 
trend and are in close agreement with the studies of MacKenzie (1965). 
Minor differences in results can be attributed as much to the 
relative inaccuracy of the methods as to biological variation. 
Systemic vascular resistance did not differ significantly 
between the 3 groups of patients. The systemic vascular resistance 
is the resultant of the vascular resistances of all vascular beds 
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in the systemic circulation and cannot be equated with regional 
vasomotor tone. Nevertheless the concept of total systemic vascular 
resistance can be useful. If systemic resistance were consistently 
increased, the shock state might be viewed as a net vaso- constrictio 
conversely , if resistance were consistently decreased a net 
vaso- dilatation would exist. In this series as in the reports of 
MacKenzie (1965) Shubin et al. (1968), Gunner et al. (1966) in the 
shocked patients systemic vascular resistance showed no consistent 
trend. MacKenzie (1965) had demonstrated that vaso- constriction 
in these patients was by no means maximal as patients could produce 
a marked increase in systemic vascular resistance during the act 
of vomiting. He suggested that the characteristic abnormality was 
a failure to elevate resistance rather than the presence of an 
excessive resistance. Smith et al. (1967) suggested that hypoxia 
and acidosis might diminish the normal vaso- constrictor response. 
Indeed if shocked patients are given vaso- pressor therapy, there is 
an increase in mean arterial pressure (MacKenzie 1965, Smith et 
al. 1967), but at the expense of a decrease in cardiac output. At 
present it would seem wise to interpret changes in total systemic 
vascular resistance with caution. More attention should be 
directed at regional perfusion and blood flow for the changes in 
regional blood flow in low output states are probably of more 
importance in determining the precise metabolic responses in acute 
myocardial infarction and in the development of shock complicating 
infarction. 
(i0 
The elevated right atrial pressures found in patients with left 
ventricular failure and shock support the concept of increasing left 
ventricular dysfunction with increasing clinical severity. This 
finding is similar to that of MacKenzie (1965) but the measurement 
of pulmonary arterial pressures extends the studies by MacKenzie. 
Pulmonary arterial pressure was raised in 8 of the 26 patients with 
uncomplicated myocardial infarction. Radiological changes 
suggestive of left sided failure were noted in 7 of the patients 
with so- called 'uncomplicated' myocardial infarction and 5 of these 
were patients with raised pulmonary arterial pressures. Lassers, 
George, Anderton, Higgins and Philp (1970) in a study of patients 
with atrio- ventricular and bundle branch block complicating acute 
myocardial infarction had also noted that radiological changes were 
in general associated with increased pulmonary arterial pressures, 
but in a number of patients there were radiological changes of left 
heart failure without elevation of pulmonary arterial pressures. 
Radiological changes of pulmonary oedema may persist after transient 
elevation of left heart pressures. 
In all the patients with left ventricular failure and with 
cardiogenic shock, pulmonary arterial pressures were raised. It 
might even be considered somewhat surprising that pulmonary arterial 
pressures were so high in the group with shock in view of the 
marked reduction of cardiac output and systemic pressure in this 
group. 
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Recently Field and Cotes (1970) studied the relationship of 
pulmonary artery pressure to cardiac output in patients with chronic 
bronchitis. The pulmonary arterial mean pressure was similar in 
patients with and without breathlessness, but the relation of 
pulmonary artery pressure to cardiac output was higher in the group 
with breathlessness. Breathing oxygen during exercise led to a 
reduction in pulmonary arterial pressure in all subjects, but not 
to a change in the slope of the mean pressure flow curve. Although 
they were using their data as evidence of a vascular sluice effect 
in the pulmonary circulation, their report is a useful reminder of 
the importance of considering pressure in relation to flow. Thus 
the pulmonary arterial pressures recorded in cardiogenic shock are 
indeed high in relation to the low cardiac outputs demonstrated in 
this condition. 
The relationship of pulmonary artery pressures to left 
ventricular pressures has been questioned and is the subject of a 
number of studies. Sapru (1966) found a close correlation between 
pulmonary arterial wedge pressure and left ventricular end -diastolic 
pressure in patients with left ventricular failure, although such a 
close relationship was not found by Linden and Allison (1963), 
Kaltman, Herbert, Conroy and Kossman (1966) were able to show that 
in the absence of mitral valve obstruction, diastolic pulmonary 
arterial pressures closely correlated with left ventricular end - 
diastolic pressures in patients with congenital and acquired heart 
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disease. Lassers et al. (1970) found a good correlation between 
diastolic pulmonary arterial pressure and pulmonary arterial wedge 
pressure in patients with acute myocardial infarction. There was 
also a good correlation between mean pulmonary arterial pressure 
and pulmonary arterial wedge pressure. In this study because of 
poor frequency response of the earlier micro -catheter systems, only 
mean pulmonary arterial pressure was recorded. With better catheter 
systems and adequate frequency response in the portable recording 
system, pulmonary artery diastolic pressures would be easily 
obtained. 
Although left ventricular pressures were not measured in the 
patients in this study, the high mean pulmonary arterial pressures 
demonstrated in the patients with shock or failure, suggest that 
both groups had severe impairment of left ventricular function. 
There was no evidence of a low filling pressure in any of the 
shocked patients and there was no evidence of hypovolaemia. The 
consistent pattern demonstrated in this study suggests that patients 
with cardiogenic shock represent the most severe reaction to left 
ventricular infarction with haemodynamic evidence of left 
ventricular failure. 
However, it must be considered that not all patients with 
cardiogenic shock have the same haemodynamic pattern. It is 
possible that patients who had had diuretic therapy before 
infarction, who are seen many hours after infarction, or have been 
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treated with vaso- pressors after infarction, might present with 
cardiogenic shock due to volume depletion. None of the patients 
in this series were treated with vaso- pressors and all were studied 
shortly after admission. Detailed examination of the case reports 
by Nixon's group (Nixon et al. 1966, 1967 and 1968a, b, a) suggest 
that all of the cases they studied were somewhat abnormal in that 
shock developed after prolonged treatment, in association with 
arrhythmias or after surgery. Until there is more evidence on this 
point, it would seem wise that all patients with cardiogenic shock 
should have some monitor of left heart pressures. For the present 
pulmonary arterial pressures are probably adequate but in the future 
direct readings of left ventricular pressures are more likely to 
be widely used. The relationship between right atrial pressure and 
mean pulmonary arterial pressure shown in fig. 10 is too wide to 
allow indirect estimation of pulmonary arterial pressures in 
individual patients. 
The present studies confirm the high incidence of arterial 
hypoxaemia in acute myocardial infarction demonstrated by MacKenzie 
et al. (1964), McNicol et al. (1965) and Valentine et al. (1966); 
although hypoxaemia was marked in patients who were critically ill, 
the arterial oxygen tension was equally low in patients with left 
ventricular failure and cardiogenic shock. By use of data obtained 
whilst the patients were breathing air, the majority of patients 
could be demonstrated to have an increase in venous admixture 
(group 116 + 2.2%; group II 22 + 5.3%; group III 36 + 8.3 %). 
6 
Formal studies with high levels of oxygen were only carried out in 
the patients with cardiogenic shock and in one patient with left 
ventricular failure. If the venous admixture was due to veno- 
arterial shunting then there would be little change in the degree 
of admixture after breathing high levels of oxygen. Fig. 15 shows 
venous admixture whilst breathing air (Qva) and oxygen (Qs) and one 
can conclude that the arterial hypoxia in cardiogenic shock is due 
to abnormalities both in ventilation perfusion ratio and in veno- 
arterial shunting. In the patients with uncomplicated acute 
myocardial infarction, arterial oxygen tensions whilst breathing 
approximately 65% oxygen ranged from 225 to 400 mm Hg. Approximate 
estimates of the veno- arterial shunt (Qs) at this high level of 
oxygen in the inspired gas suggest that the true shunt in this group 
is low (< 10 %) and that the major cause of arterial hypoxia in this 
group is due to abnormal ventilation- perfusion ratios. 
This data is similar to that of McNicol et al. (1961) and 
Pain, Stannard and Sloman (1967) but is in contrast to the results 
of Valentine et al. (1966). Valentine and colleagues had suggested 
that ventilation perfusion imbalance was the major cause of hypoxaemi 
in acute myocardial infarction. Pain, Stannard and Sloman (1967) 
had found abnormal veno- arterial shunting together with defects in 
the matching of pulmonary ventilation to pulmonary blood flow. They 
did not relate their findings to clinical severity but the present 













The relationship of venous admixture (Qva) to "true" shunt (Qs) 
in 6 patients with shock and one patient with left ventricular 
failure complicating acute myocardial infarction. If hypoxaemia were 
due to veno- arterial shunting alone, then the points would lie along 
the line of identity. 
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there is an abnormal ventilation perfusion pattern and in those who 
are seriously ill there is in addition an increase in veno- arterial 
shunting. 
By use of a radioactive xenon technique, Kazemi, Parsons, 
Valenca and Streider (1970) have shown that after acute myocardial 
infarction there is a marked reduction in perfusion to the lung base 
and increased perfusion to the apex. The pattern of perfusion 
abnormality is probably a reflection of the increase in pulmonary 
venous pressures. 
Disturbances of ventilation might be caused by narrowing of 
airways owing to intrabronchial or peribronchial oedema due to 
congestion of lung vessels associated with a rise in left atrial 
pressure. The failure to obtain normal oxygen tensions in the more 
severely ill patients after oxygen therapy suggests non -functioning 
gas exchanging units. These may be filled with alveolar exudate, or 
collapsed due to marked peribronchial cuffing or to loss of alveolar 
surfactant. In cardiogenic shock abnormalities of gas transfer may 
be increased by the low flow through the lung but the similarity of 
findings in shock and left ventricular failure suggests that the 
major defect is associated with pulmonary oedema. 
The increase in carbon dioxide tension in pulmonary oedema was 
first noted by Anthonisen and Smith (1965). In a 6 month period, 4 
patients were admitted to the Royal Victoria Hospital, Montreal, with 
a marked respiratory acidosis complicating acute pulmonary oedema. 
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Avery, Samet and Sackner (1970) made a study of 109 patients with 
pulmonary oedema. They excluded patients with cardiogenic shock, 
cardiac arrest, chronic bronchitis, chronic uraemia or diabetic 
ketoacidosis. Fifty -five of their patients had a combined metabolic 
and respiratory acidosis. In the present study one patient with 
left ventricular failure had chronic bronchitis and his PaCO2 
remained elevated after recovery from infarction, but in the other 
patients with left ventricular failure and a raised PaCO2 there was 
no evidence of co- existing disease. The administration of opiates 
does produce an increase in carbon dioxide tensions (Chapter VI), 
but usually only 5 mm Hg. Carbon dioxide retention in the patients 
with severe left ventricular failure is probably due to inability 
to maintain an adequate minute ventilation because of extensive 
airway collapse and obstruction by oedema fluid and foam. Higgs 
(1968) has shown a large increase in dead space tidal volume (Vd /Vt) 
ratio in patients with pulmonary congestion following acute 
myocardial infarction. With an increased physiological dead space, 
an apparently adequate minute ventilation may be insufficient to 
maintain normal carbon dioxide tensions. Two of the patients with 
cardiogenic shock had also elevated carbon dioxide tensions 
suggesting that similar mechanisms are operative in both cardiogenic 
shock and left ventricular failure. The identification of patients 
with respiratory acidosis is important as therapy with intermittent 
positive pressure ventilation will correct the acidosis. Estimation 
of blood gases should be part of a routine service for patients 
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with shock or failure complicating acute myocardial infarction. 
MacKenzie et al. (1964) had shown that patients with acute 
myocardial infarction with shock had a significant metabolic acidosis. 
Neaverson (1966) examined 50 consecutive cases of acute myocardial 
infarction, admitted to the Barnet General Hospital. He showed that 
60% had a significant base deficit and the more severe the base 
deficit, the more likely were there to be complications. In the 
present study, patients with uncomplicated myocardial infarction did 
not have a metabolic acidosis. The patients with left ventricular 
failure had a mixed pattern some with a respiratory alkalosis and 
some with a mixed respiratory and metabolic acidosis. The patients 
with cardiogenic shock all had a marked metabolic acidosis. Kirby, 
and McNicol (1966) reported the acid -base status in 123 patients with 
acute myocardial infarction. In 28 patients the pH was less than 
7.35. In 24 of these 28 patients, the acidosis was associated with 
a fall in plasma bicarbonate; in the remaining 4 it was with an 
increased carbon dioxide tension. Blood lactic acid levels were 
raised in patients with hypotension and left ventricular failure. 
In the present study, lactic acid levels were only measured in 
patients with cardiogenic shock, the mean level was 4.79 mmol /1 with 
a range of 1.64 to 12.9 mmol.1. In studies, not yet reported, of 
patients with hypoxaemia from differing causes, we have only found 
lactic acid levels above the upper limit of normal (1.74 mmol.l) in 
patients with cardiogenic shock. Weil and Afifi (1970) have recently 
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shown that lactate alone serves as a reliable indicator of the 
severity of shock from varying causes and that neither lactate 
pyruvate ratio nor excess lactate improve the prognostic index. The 
increased lactic acid must be produced by tissue hypoxia, but 
reduction in cardiac output may also cause a reduction in hepatic 
blood flow so that the normal uptake of lactate by the liver is 
reduced or even reversed (Berry, 1967). Studies of regional blood 
flow and of liver function in patients with low output states 
complicating acute myocardial infarction, can determine the precise 
role of the liver in the shock states. Future therapeutic approaches 
might then be directed to improving specific organ blood flow. 
Patient TA merits special comment. This patient was a known 
mild diabetic controlled on phenformin. Whilst convalescing from a 
slight cerebro- vascular episode, she developed central chest pain. 
On admission to hospital she had all the clinical features of shock. 
Her electrocardiogram showed an anterior intramural myocardial 
infarction. Blood gas analysis revealed a severe metabolic acidosis 
(pH 6.95, pCO2 19 mm Hg). Her blood lactic acid was 6.42 mmol /1. 
Blood sugar was 228 mg 100 ml, and there was no ketonuria. This 
patient did not have diabetic ketoacidosis but the role of 
phenformin in the development of her severe metabolic acidosis must 
be questioned. The precise mode of action of this drug remains 
unclear, but what is certain is that it promotes lactic acid 
production. The drug interferes with cellular aerobic metabolism, 
perhaps by inhibition of cytochrome oxidase or of NAD dependent 
oxidative phosphorylation (Oliva, 1970). Since 1962, 18 cases have 
been described with clinically severe lactic acidosis occurring in 
phenformin treated patients. Most of the patients were in shock or 
had other recognised causes of lactate overproduction. It has been 
suggested that phenformin may aggravate the lactic acidosis, 
occurring in patients with shock (Bernbr, Miller and Springate, 1963 
In the present case the precise role of phenformin in uncertain, but 
the metabolic acidosis in this patient was much greater than in the 
other patients with cardiogenic shock. 
Mixed venous oxygen saturation was reduced in all but 2 patient 
below the normal level of 70% suggested by Zimmerman (1966). The 
lowest mixed venous oxygen saturations were found in those patients 
with left ventricular failure and cardiogenic shock. These findings 
are in agreement with previous reports of the correlation of venous 
oxygen saturation with clinical condition (Goldman, Klughaupt, 
Metcalf, Spivack and Harrison, 1968, Scheinman et al. 1969). In 
patients with cardiogenic shock, the low levels of mixed venous 
oxygen saturation (SvO2) were recorded when the patients were 
breathing high flow oxygen. It is likely that SvO2 would be lower 
still in these patients in the absence of oxygen therapy. 
Goldman et al. (1968) suggested that although central venous 
oxygen saturation reflected the clinical condition of the patient, 
it could not be used to predict the cardiac output. The data in this 
study suggests a close relationship between cardiac output and mixed 
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venous oxygen saturation. The measurement of cardiac output may not 
be a practical procedure in the majority of units caring for patients 
with acute myocardial infarction, but pulmonary arterial 
catheterization by the float technique is a relatively simple and 
safe procedure. This allows the measurement of mixed venous oxygen 
saturation and provides a rational basis for management of patients 
with shock or failure complicating acute myocardial infarction using 
the minimum of equipment. 
THE EFFECTS OF DIGOgIN, ACID -BASE COPRECTION AND 
VOLUME LOAD ING IN CARD IOGMTIC SHOC B 
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CHAPTER IV 
The findings reported in the previous chapter give a basis for 
devising an appropriate therapeutic regime for the management of 
cardiogenic shock. As the most striking haemodynamic finding was of 
increasing left ventricular failure with increasing degrees of 
clinical severity, therapy to correct cardiac failure would seem 
appropriate. Digitalis was first suggested for the treatment of 
severe grades of acute myocardial infarction by Herrick (1912). 
Levine and Brown (1929) recommended digitalis for those with manifest 
congestive failure but held that it was best avoided in most cases 
as it was 'more likely to do harm than good'. Fishberg et al. (1934) 
also warned of the dangers of digitalis and postulated that it could 
cause increased irritability of the heart, increased liability to 
embolisation and coronary artery vaso- constriction. They also 
held that it might increase the force of systolic contraction and 
predispose to rupture. 
The view held by Goodman and Gilman (1965) is of interest. 
"Digitalis is contra -indicated during the first few days following 
acute coronary thrombosis. The clinical picture is usually one of 
shock rather than congestive failure and digitalis by further 
decreasing the cardiac output, may make the patient worse ". Of the 
standard text books in cardiology, Hurst and Logue (1970) emphasise 
that the altered physiology in cardiogenic shock is poorly 
understood, but recommended that digitalis should be given in the 
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early stage of shock. Freidberg (1966) states that the value of 
digitalis in shock is not established and requires further study. 
In both text books digitalis is advocated for left ventricular 
failure complicating acute myocardial infarction. In the current 
edition of Paul Wood's Diseases of the Heart and Circulation (1968) it 
is suggested that digitalis should be used for conventional heart 
failure, but makes no mention of it in the management of shock in 
acute myocardial infarction. 
The haemodynamic effects of digitalis preparations in 
cardiogenic shock were first studied by MacKenzie (1965), He reported 
on the administration of digoxin to 6 patients with uncomplicated 
myocardial infarction and 4 patients with shock. In the patients 
with uncomplicated myocardial infarction, intravenous digoxin 
increased a previously impaired cardiac output. In contrast the drug 
had no effect when cardiac output was within the normal range. Littl- 
haemodynamic benefit was demonstrated when digoxin was administered 
to the 4 patients with cardiogenic shock. He postulated that the 
coincidental metabolic acidosis blocked the usual cardiotonic effect 
of digoxin. An appropriate therapeutic approach might combine 
correction of the metabolic acidosis with the administration of 
digoxin. 
If therapy with digoxin and acid base correction were 
unsuccessful, it might then be argued that cardiogenic shock was not 
an extreme example of left ventricular failure, as therapy known 
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to improve the failing heart (Mason and Braunwald, 1967), had been 
without effect. Several possibilities exist; the damage to the left 
ventricle might be so great that the heart can no longer respond to 
the cardiotonic action of digoxin; an alternative view is that 
of Nixon et al. (1966) and Ross (1967) when they held that cardiac 
asynergy might be improved by increasing left ventricular volumes. 
A therapeutic schedule was therefore devised in which patients 
with cardiogenic shock were digitalized, their metabolic acidosis 
was corrected and if there was no improvement they were given a 
fluid load. This chapter describes the results obtained. 
PATIENTS AND PROCEDURES: Five of the patients with cardiogenic shock 
described in Chapter III were studied. The patients were given high 
flow oxygen and if pain was present, this was relieved by opiates. 
After a control period of 15 minutes, digoxin (0.75 to 1.0 mg) 
was given slowly intravenously. The variation in dose was 
conditioned by a clinical assessment of the weight of the patients. 
Metabolic acidosis was corrected using either sodium bicarbonate or 
the amine buffer Tris (hydroxymethyl) amino- methane (THAN). If there 
had been no haemodynamic or clinical response to digoxin after a 
minimum time of one hour, volume expansion was undertaken. This was 
done in an identical manner to that described by Nixon et al. (1966). 
Approximately 200 ml of 5% laevulose was given rapidly intravenously. 
If there was no response a further 200 ml of laevulose was given. 
One patient had been digitalized prior to the study and in this 
patient only the response to volume loading was studied, one patient 
died before volume expansion was undertaken. A summary of the 
therapeutic schedule is shown in Table 10. 
During the study vascular pressures and electrocardiogram were 
monitored continuously. Cardiac output determinations were made at 
5 minute intervals. Arterial oxygen and carbon dioxide tension and 
pH were measured at 15 minute intervals. 
RESULTS: 
1. Digoxin and Acid -Base Correction: 
The individual haemodynamic and metabolic responses to therapy 
with digoxin and acid -base correction are shown in figs. 16, 17, 18 
and 19. 
In the 2 patients given bicarbonate, the acidosis was corrected 
but neither the correction of the acidosis nor the administration 
of digoxin produced any marked change in haemodynamic or clinical 
state. In particular there was no significant change in cardiac 
output or stroke volume and heart rate was little affected. There 
was an increase in carbon dioxide tension after the administration 
of the bicarbonate (+ 9 mm Hg and + 14 mm Hg). 
In the 2 patients given THAM the metabolic acidosis was correct 
with little change in arterial carbon dioxide tension. There was 
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Fig. 16 
Patient TU: Circulatory and metabolic response to intravenous 
digoxin (0.75 mg) and THAM. Digoxin was administered intravenously 
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Fig. 17 
Patient PL: Circulatory and metabolic response to intravenous 
digoxin (1.0 mg) and sodium bicarbonate. 
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Fig. 18 
Patient Al: Circulatory and metabolic response to intravenous 
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Fig. 19 
Patient Li: Circulatory and metabolic response to intravenous 
digoxin (0.75 mg) and sodium bicarbonate. 
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Mean aortic pressure and cardiac output in cardiogenic shock 
before and after therapy with digoxin and sodium bicarbonate or THAM. 
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( -36 mm Hg, - 32 mm Hg). At the same time there was a fall in 
systemic arterial blood pressure with little change in cardiac 
output or stroke volume. Right atrial pressure increased in both 
patients given THAN'. 
The hypotensive and hypoxic effects of THAN persisted for 
approximately 10 minutes, making precise interpretation of the 
effects of digoxin difficult. However, in neither patient was there 
a sustained increase in cardiac output, stroke volume or systemic 
arterial pressure. 
Whether the metabolic acidosis was corrected by sodium 
bicarbonate or by THAN the decrease in hydrogen ion concentration 
was short lived and within 20 to 30 minutes, the pH had returned to 
pre -treatment levels. 
The effects of acid -base correction and administration of 
digoxin on cardiac output and systemic arterial pressure are 
summarised in fig. 20. 
2. Volume Loading: 
Individual haemodynamic responses to therapy with 5% laevulose 
are shown in figs. 21, 22, 23 and 24. After the administration of 
laevulose to patient TU, there was a rise in right atrial pressure 
from 3 mm Hg to 9 mm Hg, but the mean systemic arterial pressure 
fell from 63 mm Hg to 40 mm Hg and at the same time the pulse 
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Patient L1: Circulatory response to 400 ml 5% laevulose. 
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following the laevulose and cardiac output fell by 0.5 litres_min_m2. 
Thus the calculated stroke volume was severely reduced from 18 ml.m2 
to 11 ml.m 
2 
. With the deterioration of haemodynamic function there 
was a marked worsening of the clinical condition. The patient 
became breathless and more confused. On auscultation there were 
widespread crepitations throughout both lung fields. Fortunately 
both the clinical and haemodynamic effects were reversed by the 
intravenous administration of 5 mg heroin and 40 mg of frusemide 
(lasix), 
In the other 3 patients the administration of laevulose brought 
about neither a clinical deterioration nor a clinical improvement. 
After the infusion of laevulose there was an increase in right atria 
pressure. There was also an increase in pulmonary arterial pressure 
In patient LI, pulmonary arterial pressure rose from 32 mm Hg in the 
control period to 40 mm Hg after the infusion was completed. But 
despite the increase in filling pressures, there was little change 
in cardiac output or systemic arterial pressure. 
DISCUSSION 
Acid -Base Correction and Digoxin 
The precise influence of metabolic acidosis on cardiac 
performance is in dispute. It has been demonstrated that increasing 
hydrogen ion concentration of the circulating fluid reduces cardiac 
contractile strength in submammalian species (Burridge 1912, Daly 
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and Clark 1921, Lorkovic 1966) and in isolated mammalian heart lung 
preparations (Gremels and Starling 1926, Thrower, Darby, Aldinger, 
Tenney and Westbrook 1959, Ng, Levy and Zieske 1967). The effect 
of metabolic acidosis on intact mammalian preparations and in man is 
variable. Rocamora and Downing (1969) demonstrated in cats that, 
with sympatho- adrenal function intact, metabolic acidaemia failed 
to diminish myocardial contractility. In a survey of the literature, 
they concluded that as long as there was normal sympathetic function 
changes in pH produced little change in myocardial contractility. 
However, there was a break point below which changes in pH could 
produce altered cardiac function. Moreover there was a species 
difference, thus the cat could tolerate reduction in pH to 6.80 
whilst the dog could only tolerate reductions in'pH to 7.10. 
There are few well documented reports of the effects of 
metabolic acidosis on myocardial function in man. Reid, Enson, 
Harvey and Ferrer (1965) studied the effects of variations in the 
blood pH upon the electrocardiogram in patients with pulmonary 
disease. The pH of the patients was altered by administering 
hydrochloric acid, THAM or sodium bicarbonate. The range of pH 
achieved was 7.30 to 7.64 but no variation in the electrocardiogram 
was noted. Kirby and McNicol (1966) attempted correction of 6 
patients with metabolic acidosis complicating acute myocardial 
infarction but although they had "some success" there was 
no effect 
on mortality. Neaverson (1966) corrected the metabolic acidosis 
of 
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2 patients with acute myocardial infarction and was able to document 
an increase in systolic blood pressure in all patients. There was 
o mention of how blood pressure was measured and no further details 
of the patients were given. 
Downing, Talner and Gardner (1966) had shown that in newborn 
lambs, the combination of hypoxia and metabolic acidosis caused a 
decrease in myocardial contractility that was at least partially 
reversed by sodium bicarbonate. Metabolic acidosis alone or hypoxia 
alone did not cause a decrease in myocardial contractility. The 
severe hypoxia present in patients with cardiogenic shock might then 
aggravate the effects, if any, of the metabolic acidosis. But the 
patients described by Kirby and McNicol (1966) and the patients 
presented in this thesis, were breathing oxygen and their arterial 
hypoxia was at least partially corrected, and yet there was little 
evidence of improvement in myocardial function. 
Robin and Bromberg (1953) have pointed out the necessity of not 
oversimplifying Claude Bernard's concept of the internal environment, 
since different body compartments are separated by semi -permeable 
membranes which limit the passage of ionized particles such as /-H4-_7. 
Thus the correction of an extracellular acidosis may have little effect 
on intracellular pH; the lack of demonstrable response to sodium 
bicarbonate might be explained on this basis, and it was 
to try to 
correct intracellular pH that THAM was used. 
THAM was first used to control environmental pH 
in fish 
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transport. Nahas (1959) noted that TRAM reversed rapidly the failure 
of the isolated heart induced by perfusing the heart with elevated 
carbon dioxide mixtures, this effect could not be obtained by sodium 
bicarbonate or lactate. Robin, Wilson and Bromberg (1961) studied 
the kinetics by which TRAM leaves the extracellular compartment and 
concluded that THAM penetrates cell membrane rapidly. Because of 
the rapid penetration of the intracellular space and because it is 
a sodium free hydrogen ion acceptor, THAM seemed an ideal buffer 
for correcting metabolic acidosis in cardiogenic shock. However, 
in this study the use of TRAM produced further hypotension and 
markedly decreased arterial oxygen tensions despite oxygen therapy 
in the 2 patients given the amine buffer. Vick, Hinshaw and Spink 
(1961) had noted its hypotensive action in endotoxin induced shock 
in dogs and although THAM increased urine flow and pH in their 
experiments, it did not increase survival. They concluded that beca =e 
of its hypotensive effect THAM might actually be detrimental in 
endotoxin shock. The depression of ventilation that occurs after 
the use of TRAM was emphasised by Brinkman, Brunswick and Whitehouse 
(1961). They noted in patients with respiratory acidosis a decrease 
in arterial oxygen tension after TRAM and there was a reduction in 
respiratory minute volume. The effect of TRAM on ventilation during 
correction of metabolic acidosis does not seem to have been well 
documented. In the 2 patients with cardiogenic shock treated with 
minute ventilation was not measured but carbon dioxide tensions were 
little changed despite the reduction in arterial oxygen tensions. Thi 
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would argue an increased shunt effect in the lungs rather than a 
primary depression of ventilation: little change was noted in cardia 
output so that any shunt effect would be by alteration in perfusion 
to the lung. More precise interpretation would require detailed 
cardiorespiratory studies of the effects of TRAM. In practical 
terms the hypotension and hypoxaemia following the use of TRAM 
suggests it has little value in the correction of metabolic acidosis 
after myocardial infarction. 
Metabolic acidosis in cardiogenic shock probably represent such 
severe circulatory insufficiency that relieving arterial hypoxia 
and the correction of the entracellular acidosis has little influence 
on intracellular oxygen tension and pH in ischaemic areas of the 
myocardium. Assuming that the combination of hypoxia and metabolic 
acidosis decreases myocardial function in man, then only by 
restoring a physiological milieu to the ischaemic areas of the heart 
surrounding the infarcted areas will normal function be restored. 
With diseased coronary arteries, a low cardiac output and low 
coronary artery filling pressures, it is unlikely that a normal 
physiological milieu can be restored and abnormal cellular 
metabolism will persist. It is for this reason that many workers 
have explored various forms of mechanical circulatory assistance 
for the management of cardiogenic shock (Birtwell, Soroff, Ruiz, 
Many and Deterling 1969). With mechanical assistance at least 
cardiac output and coronary artery filling pressures can be 
increased. 
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It is also valid to consider whether alterations in acid -base 
status could alter the action of drug therapy in shock. Weil, Houle, 
Brown, Campbell and Heath (1957) reported in abstract form that the 
pressor response to vaso- pressors was diminished by acidosis. Mason 
and Braunwald (1967) have reviewed the effects of digitalis. The 
action of digitalis is to exert a positive inotropic effect by a 
direct enhancement of myocardial contractility. The fundamental 
mechanisms by which the cardiotonic actions of digitalis are mediated 
at cellular level remain to be precisely elucidated. At present 
there is not yet a full understanding of the processes involved in 
normal contraction. It appears likely that intracellular ionic 
transport underlies the coupling of the excitation- contraction 
response (Mason, Spann and Zelis 1969). The presence of active 
calcium in the region of the myofilaments appears to be intimately 
associated with the initiation of the contractile process (Nayler 
1967). Digitalis compounds probably alter the rate of calcium 
exchange and augment the myoplasmic concentration of calcium. Mason 
et al. (1969) suggested that cardiac glycosides might ultimately 
provide more calcium ions for the contractile process by a direct 
influx or by a glycoside induced influx of sodium ions displacing 
calcium from sarcoplasmic reticulum. Digitalis may inhibit the cell 
membrane pump ATPase and thus the sodium- potassium pump mechanism 
operative in diastole, resulting in less efficient return of 
potassium into the cell. 
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Whatever the precise mechanism of action of digitalis, its 
action is closely related to ion transport. In metabolic acidosis 
normal cell physiology must be altered and ion transport disturbed. 
It seems reasonable to suppose that the action of a drug which acts 
by influencing ion movement will be disturbed in metabolic acidosis. 
In this context then, it is disappointing that no beneficial effects 
of acid -base correction and administration of digoxin were noted in 
the 4 patients with cardiogenic shock. The same strictures about 
inadequate intracellular correction of the acidosis and inadequate 
relief of hypoxia are valid, in addition there may be inadequate 
distribution of digoxin because of poor coronary perfusion. However, 
the failure of digitalization and acid -base correction to improve 
clinical or haemodynamic function in cardiogenic shock suggests 
severe left ventricular damage. 
What then is the place of digoxin in acute myocardial infarctio 
The haemodynamic studies of MacKenzie (1965) had suggested that in 
patients with a low cardiac output without shock, digitalization 
improved circulatory status. Malmcrona, Schroder and Werko (1966) 
studied 10 subjects with recent transmural infarction who were 
treated with intravenous lanatoside C (0.8 mg) and found an increase 
in arterial pressure but no significant change in cardiac output. 
Balcon, Hoy and Sowton (1968) studied 11 patients with recent acute 
myocardial infarction: only 2 patients had radiographic evidence of 
pulmonary venous congestion and the highest recorded mean pulmonary 
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arterial pressure was 19 mm Hg. After the intravenous injection of 
0.25 mg acetyl beta strophanthidin (7 cases) or 0.5 mg digoxin 
(4 cases) they noted a fall in cardiac output (14 %) with no change 
in pulmonary arterial pressure, aortic pressure or peripheral 
resistance. 
Apart from the studies reported in this thesis and by MacKenzi 
(1965), haemodynamic effects of digitalization in cardiogenic shock 
have also been reported briefly by Gunnar, Loeb, Pietras and Tobin 
(1970). In a review article on the haemodynamic effects of 
myocardial infarction and the results of therapy they showed in 
diagrammatic form the results of digitalization in patients in shock 
with acute myocardial infarction in 12 patients, 8 of whom were 
simultaneously receiving an infusion of noradrenaline. In only one 
patient did cardiac output increase by more than 15% and the average 
change from the control levels was -6 %. In most patients central 
venous pressure was reduced but changes in systemic arterial pressure 
were variable. No further details were given but the authors 
concluded that digitalis should be given to patients with cardiogenic 
shock. Braunwald (1970) has suggested from experimental work that 
digitalis increases oxygen demand of the heart and that in dogs with 
cardiogenic shock the administrat.on of digoxin caused an increase 
in the size of the infarcted area. However, claims about oxygen 
consumption of the heart must be viewed with caution. For in heart 
failure, the reduction in size of the failing heart brought about 
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by digitalis may lower the heart's demand for oxygen more than the 
direct effect of the agent on contractility increasing oxygen 
demand (Covell, Braunwald, Ross and Sonnenblick 1966). 
The reports of other experimental studies are almost as 
confusing. Cronin and Zoster (1965) studied the effects of rapid 
digitalization in dogs with experimental cardiogenic shock. They 
reported a significant rise in arterial blood pressure and cardiac 
output with a reduction in left ventricular end -diastolic pressures. 
The administration of noradrenaline raised cardiac output at the 
expense of a further elevation in left ventricular end- diastolic 
pressure. In contrast to this Hood, McCarthy and Lown (1967) studied 
dogs with experimental myocardial infarction and concluded that acetyl 
strophanthidin caused no improvement in left ventricular function. 
Marano, Kline, Cestero and Kuhn (1966) produced shock in dogs by 
microsphere embolization. The administration of ouabain produced a 
significant rise in cardiac output and arterial pressure. Left 
ventricular function, as judged by changes in the maximum rate of 
pressure rise in the left ventricle (dp /dt) was also increased. No 
such changes were found in control animals without infarction. 
Although there is no satisfactory account of the action of 
digitalis in patients with left ventricular failure complicating 
acute myocardial infarction, it is probably in this group that 
digitalization will be most effective. Beneficial effects in an 
uncomplicated group may be difficult to demonstrate with 
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conventional techniques; where improvement in clinical and 
haemodynamic state in the so- called uncomplicated group occurs after 
digitalis therapy, it is likely that underlying cardiac failure had 
not been noted. The haemodynamic studies demonstrated in Chapter 
III emphasise that in a considerable number of patients, left 
ventricular failure is difficult to diagnose without the aid of 
radiological and haemodynamic investigations. 
For the physician having to treat cardiogenic shock without the 
aid of bedside physiological information, it would seem wise to 
regard the situation as one of masked left ventricular failure 
and to administer digitalis. Although the haemodynamic studies 
reported here and those reported by MacKenzie (1965) failed to 
demonstrate any beneficial effect of digoxin in cardiogenic shock, 
the studies were carried out on patients with unequivbcal shock. The 
studies reported in Chapter III suggest there is an increasing degree 
of left ventricular disorder with increasing clinical severity and 
there is no sharp distinction between patients with severe left 
ventricular failure and cardiogenic shock. Although studies are 
needed to demonstrate any potentially beneficial effects of digitalis 
in patients with left ventricular failure, at the present time it 
would seem correct to administer digoxin to patients with cardiogenic 
shock. By improving left ventricular contractility an adequate 
cardiac output might be obtained. An adequate cardiac output would 
correct tissue hypoxia and reverse the metabolic acidosis. Although 
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it seems probable that in most patients with cardiogenic shock the 
damage to the ventricle is so great that digitalization cannot 
improve cardiac function, individual patients may have a satisfactory 
response to digitalis therapy. The hazards of digitalis excess must 
be carefully considered, but the frequency of digitalis induced 
arrhythmias seems to be no greater than in other cardiac emergencies 
requiring its use (Askey 1951). 
Volume Expansion 
The report of low left ventricular pressure in cardiogenic shock 
by Nixon (1968) and the successful response to therapy with volume 
expansion reported by Nixon and his colleagues (1966, 1967, 1968a, 
b, c) and by Swan et al. (1969) have suggested that a number of 
patients could be improved by volume expansion. The precise number 
is uncertain. Allen, Danzig and Swan (1967) reported in abstract 
form on the incidence and significance of relative hypovolaemia as a 
cause of shock associated with acute myocardial infarction. In 29 
patients with cardiogenic shock, right atrial pressure was measured, 
in 14 of those patients the right atrial pressure was less than 
10 cm H2O. However, Cohn, Khatri and Hamosh (1969) reported again 
in abstract form, a study of left ventricular pressure in 22 patients 
with either cardiogenic shock or pulmonary embolism. In all patients 
with cardiogenic shock, left ventricular end -diatolic pressure was 
elevated (range 12 to 44 mm Hg) even when the central venous pressure 
was normal. The rapid deterioration of patient TU with a small 
volume load (200 ml) suggests that this patient was precipitated into 
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frank pulmonary oedema by the therapy. This patient had a low right 
atrial pressure (5 mm Hg) and although pulmonary arterial pressure 
was not obtained during volume expansion, this had been measured 
during digoxin therapy and was only slightly elevated (21 mm Hg). 
This patient then had the lowest right sided pressures of the patients 
treated with volume expansion but it was in this patient that the 
therapy caused such a dramatic deterioration. The other patients 
treated with laevulose showed neither clinical deterioration nor 
improvement, but the increase in pulmonary arterial and right atrial 
pressure without an increase in cardiac output or systemic arterial 
pressure were strong indications that these patients were in extreme 
left ventricular failure. When changes in venous pressure are 
plotted against changes in cardiac output, a very flat response 
is obtained (fig. 25). By reference to the data of Sarnoff and 
Berglund (1954), the response obtained is that of the failing heart 
and in patient TU the decrease in cardiac output with increase in 
right atrial pressure indicates that the downslope of the Starling 
curve has been reached (Patterson and Starling 1914). In these 
patients there is absolutely no evidence of hypovolaemia. 
A large number of clinical reports of intravenous therapy in 
cardiogenic shock have not shown any alteration in the relief of 
shock and the mortality rate was no better than with non -specific 
therapy (Epstein and Reiman 1949, Sampson and Singer 1949, Cochran 
1952, and Binder, Ryan, Marcus, Mugler, Strange and Agress 1955). 
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Fig. 25 
The change in cardiac output with increments in right atrial 
pressure in cardiogenic shock. 
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such a large number of patients suggests the number of patients 
who might respond to volume loading therapy is small. Nevertheless, 
volume depletion might occur where patients have been previously 
taking diuretic therapy, where there has been profuse sweating or 
diarrhoea or where infarction has occurred after major surgery. 
There may also be loss of fluid from intravascular compartment 
at the time of circulatory arrest. As no well documented 
haemodynamic studies of volume depletion in acute myocardial 
infarction have been made there is an urgent need for more 
information about left heart pressures in cardiogenic shock. 
A Starling (function) curve of a ventricle does not reflect 
the state of all the fibres of that ventricle. Ischaemic areas and 
infarcted areas of the heart must operate on different function 
curves (Harrison 1965). Gorlin, Klein and Sullivan (1967) reported 
an angiographic study of 100 patients with coronary artery disease. 
Twenty -four patients manifested abnormal movements of the left 
ventricle which they classified as akinesis (lack of wall movement) 
and dyskinesis (paradoxical wall movement). Akinesis was present 
in 16 and dyskinesis in 8 patients. Contrary to expectation, 
aneurysms composed solely of thin- walled fibrotic areas occurred 
in only 7 of 16 patients observed directly at necropsy or surgery. 
Krohn, Dunne, Magidson, Hanish, Tsuji, Redington and Kay (1968) 
reported an angiographie study of 20 cases of arteriosclerotic and 
valvular heart disease. During systole a limited portion of the 
ventricular wall failed to contract properly. The paradoxical bulge 
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was also recorded by the electrical impedance cardiogram, which 
measures changes in electrical resistance in the thorax related to 
instantaneous changes in heart shape. In left ventricular failure 
the apex dilated paradoxically in systole. In the La Place relation 
the intracavitary pressure would equal the muscle tension divided 
by cavity radius. Because of the abnormal increase in the radius 
at the apex the thin apical muscle would have to contract almost 
as strongly as the base to sustain intracavitary pressure. But this 
interpretation of the La Place equation must be accepted with some 
reservation; the law applies to situations in which the thickness 
of the wall is negligible in comparison to the radius of curvature, 
Studies of left ventricular function in experimental acute 
myocardial infarction (Pairolero, McCallister, Hallerman and Ellis 
1970) have shown a measurable decrease related to the size of 
the infarct. It is likely that an asynergic area develops in most 
cases with acute myocardial infarction. In the majority this causes 
only minor changes in left ventricular function, in some however, 
akinesis or dyskinesis is more marked and probably contributes to 
the left ventricular failure of cardiogenic shock. 
Ross (1967) has argued that when ventricular filling pressure 
is relatively normal or even moderately elevated a depressed ventricl 
can operate on the ascending portion of its Starling curve. He 
therefore advocated volume expansion to try to make optimum use of 
the intrinsic mechanism for augmenting the force and extent of fibre 
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shortening. Nixon et al. (1966) suggested that the infusion and 
elevation of venous pressure had acted beneficially in his cases by 
distending the ventricle to the point at which its output maintained 
life. 
That the elevation of venous pressure brought about no 
improvement in cardiac output of the patients presented in this 
chapter, does not suggest that ventricular dyskinesis or dysynergy 
is unimportant in cardiogenic shock. Indeed the concept of 
localised left ventricular dysfunction in cardiogenic shock needs 
detailed study, for it is possible that some patients could be 
improved by an immediate surgical approach involving surgical 
excision or placation (Milstein 1970). But the lack of response 
to therapy with digoxin, acid -base correction and volume loading 
suggests that in the patients so treated, the left ventricular 
damage was so great that the heart could no longer respond to any 
therapeutic measure. The rapid production of pulmonary oedema in one 
patient emphasises the dangers of treatment with volume expansion 
in cardiogenic shock and also emphasises that shock and failure in 
acute myocardial infarction are very much part of the same response 
to ventricular damage. 




The use of opium as a medicament dates back to antiquity. The 
Papyrus Ebers (approximately 2,000 B.C.) mentions the power of opium 
to obtund pain. Poppy juice was referred to in the writings of 
Theophrastus in the third century B.C. Galen employed opium to 
relieve pain and opiates were used by Arabian physicians in the dark 
and middle ages. By the middle of the sixteenth century, opium was 
widely used in Western Europe. Paracelsus (1490 -1540) is credited 
with naming the extractive preparation, tincture of opium, Laudanum 
from the Latin 'laudo' I praise. By 1680 the English physician 
Sydenham had written that of the drugs to relieve suffering 'none 
is so efficacious as opium'. The history of opium in antiquity has 
been reviewed by Macht (1915). 
However, it was not until the isolation of morphine from opium 
by Serturner in 1806 that pharmacological studies on opiates 
commenced. He administered his 'morphium' to dogs and described its 
narcotic effect. Despite the isolation of many other alkaloids 
during the following century, morphine remains the chief member of 
the group and is the standard for comparisons with newer analgesics. 
Opium is defined by Martindale's Extra Pharmacopeia as 'the dried 
or partly dried latex obtained by incising the unripe capsules of 
Papaver somniferum (Fam. Papaveraceae)'. The pharmacologically 
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active constituents are alkaloids. The main alkaloids in opium are 
of the phenanthrene chemical class and consists of morphine, codeine 
and thebaine. Morphine is by far the most important alkaloid of 
opium. It chemical structure was first proposed by Gulland and 
Robinson in 1925 and confirmed by total synthesis by Gates and 
Tschudi (1952). Its structure is shown in fig. 26. Many of the 
derivatives of morphine are made by the introduction of relatively 
simple chemical radicals into the hydroxy groups of the morphine 
molecule. Thus heroin (diacetyl morphine) is synthesized by 
acetylation of both hydroxy groups. Codeine is methylmorphine, the 
methyl substitution being on the phenolic OH. Small substitutions 
of this nature can produce compounds with very different 
pharmacological actions emphasising the importance of both the 
phenolic and alcoholic hydroxy groups (Beckett 1952). 
The pharmacology of opiates has been extensively studied and 
there exists a number of comprehensive reviews (Kreuger, Eddy and 
Sumwalt 1941, Reynolds and Randall 1957, Eckenhoff and Oech 1960). 
The actions of opiates upon the cardiovascular system have received 
less attention than have the effects on respiration. Most 
authorities are agreed that the main consequence of administration 
of an opiate on the circulation is to produce hypotension. There 
are clinical reports of hypotension occurring after all narcotics 
and these have been summarised by Eddy, Halbach and Braenden (1957). 
Of more practical significance would be a comparison of the incidence 
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Fig. 26 
The chemical structure of morphine and heroin (diacetyl 
morphine). 
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of hypotension produced by the various opiates. However, comparative 
data is lacking and few narcotics have been tested in a manner which 
allows comparison (Eckenhoff and Oech 1960), The main reason for 
lack of comparative data has been the minimal response in normal 
volunteers unless some stress was laid on the circulation. To date, 
the commonest stress used when assessing the action of opiates has 
been a gravitational one using a 'tilt -table'. Drew, Dripps and 
Comroe (1946) using a tilt -table demonstrated that 12 -30 mg of 
morphine intramuscularly produced marked hypotension in 76 degrees 
head -up position. Bandaging the legs lessened the hypotension. The 
authors concluded that morphine led to peripheral vascular dilatation 
and dilatation of the capacitance vessels. Similar results were 
reported by King, Elder and Dripps (1952) using pethidine in 
hospitalized patients. 
Although morphine has been recommended for the relief of pain 
following acute myocardial infarction ever since the early clinical 
description of the syndrome (Herrick 1912 and Moor 1930), little 
attention has been focussed on its cardiovascular actions in this 
disease. In 1965 Thomas and his colleagues administered morphine 
sulphate (3 to 10 mg) to 13 patients with acute myocardial 
infarction and studied the haemodynamic effects. Two of the 
patients were studied twice. Cardiac output was measured using a 
dye dilution technique with Coomassie blue dye as the indicator; 
changes in dye concentration were measured by a photoelectric 
earpiece. Their information was presented in graphical form and 
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precise interpretation is difficult. In 7 instances, cardiac output 
was unchanged and in 8 patients cardiac output was decreased. In 
2 patients the initial cardiac output was greater than 10 litres 
per min. Changes in heart rate were variable but in 2 patients the 
heart rate slowed and in one of those the heart rate slowed to 20 
beats per min. A fall in blood pressure was recorded in 8 patients 
and in one patient the systolic pressure fell to 30 mm Hg but with 
a concomitant bradycardia. No statistical analysis of the data 
was undertaken. Using values from their graphical data, the fall in 
blood pressure for the group is not statistically significant when 
assessed by a paired 't' test. Although the authors were cautious 
in the interpretation of their data, this single study has been 
widely quoted since as adequate evidence that morphine can produce 
marked hypotension in acute myocardial infarction. 
Two years later in a study from this department, we examined 
the circulatory effects of heroin administered to 8 patients with 
recent myocardial infarction (MacDonald, Rees, Muir, Lawrie, Burton 
and Donald 1967). There was a mean fall in aortic pressure of 5 
mm Hg after the administration of heroin. This fall in blood 
pressure achieved statistical significance at the 5% level but 
cardiac output, systemic vascular resistance, heart rate, stroke 
volume, right atrial and pulmonary arterial pressures showed no 
significant trend. These studies suggested that heroin might be 
preferable to morphine in the relief of pain following acute 
myocardial infarction. However, the data was not stricy comparable 
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as dosage levels and investigational techniques were dissimilar. In 
the search for a more suitable analgesic agent for use in myocardial 
infarction, we have also examined the circulatory effects of pethidine 
(Rees, Muir, MacDonald, Lawrie, Burton and Donald 1967). This was 
found to produce a biphasic action on the circulation with an initial 
rise in mean systemic pressure ( +12 mm Hg) followed in 10 -15 minutes 
by a fall to a mean pressure 10 mm Hg below the control level. There' 
was also a rise in systemic vascular resistance and heart rate in the 
first 10 -15 minutes and then a fall in these variables below control 
levels. This was in accord with previous data from normal subjects 
(Prescott, Ransom, Thorp and Wilson 1949). It seemed that pethidine 
was an unsuitable analgesic to administer after a recent myocardial 
infarction and that in our experience heroin was preferable. 
The recent increase in the number of heroin addicts in the U.K. 
encouraged us to try to determine more precisely whether heroin had 
any major advantages over the more standard regime of morphine. The 
present study was undertaken to make a thorough assessment of the 
circulatory side effects of these two opiates in myocardial 
infarction. Because of the inherent difficulties in algesimetric 
methods, no attempt was made to assess their capacity to relieve 
pain. 
General Outline 
The study was conducted in two parts. In the first instance, 
the circulatory effects of 10 mg of morphine were examined in 8 
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patients with recent myocardial infarction. This study was conducted 
in an identical manner to that of the previously reported heroin 
study (MacDonald et al. 1967). A further 3 patients received an 
antihistaminic drug, cyclizine, prior to the administration of 
morphine. These studies are reported in this chapter. 
As these studies showed no important difference between the 
effects of morphine and heroin a second more detailed study was 
undertaken in which the effect on blood pressure, heart rate and 
blood gases of heroin and morphine administered on a 'blind' basis 
to 27 patients with recent myocardial infarction were studied. This 
study is reported in Chapter VI. 
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THE CIRCULATORY EFFECTS OF MORPHINE 
Methods: 
The personal characteristics and clinical details have been 
listed in Table 3, but for convenience are grouped together in 
Table 11. 
Eleven patients were studied, all had sustained an acute 
myocardial infarction as judged by World Health Organisation (1959) 
criteria within the previous 36 hours. The patients were all in 
sinus rhythm and were not shocked nor in clinical heart failure. No 
patients had received any drug therapy within the 12 hours preceding 
the investigation. The investigations were conducted with the patie is 
in their own beds in the clinical investigation and therapy area. 
The patients were studied lying supine in bed with one pillow 
supporting the head. Control observations were made in each patient 
over a period of 20 minutes. In 8 patients, 10 mg of morphine 
diluted in 10 ml of saline was then injected intravenously over a 
period of 5 minutes and observations were continued for a further 
60 minutes. In addition 3 patients were treated with antihistamines 
prior to the administration of morphine; 50 mg of the antihistaminic 
drug, cyclizine, was administered intramuscularly 20 minutes prior 
to the injection of 10 mg of morphine. 
The electrocardiogram was recorded continuously throughout 
the study. Systemic arterial, pulmonary arterial and right atrial 
pressure recordings were interrupted only for the sampling of 
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arterial and mixed venous blood. Cardiac output determinations were 
made at 5 minute intervals throughout the study. 
A paired 't' test was applied to the differences between the 
mean values during the control period in each patient and the 
measurements recorded at 5, 10, 20, 30, 40 and 50 minutes after the 
start of the injection, the null hypothesis being that the difference 
would be zero. 
Comparison of Circulatory Effects of Morphine with those of Heroin: 
The results obtained after the administration of morphine were 
compared with our results, previously reported, of those patients 
who had received heroin (MacDonald et al. 1967). This paper is 
included in the appendix. In the heroin study 2 patients had been 
studied in a tilted position and they are excluded from the present 
comparison. The results of observations following the administration 
of heroin to 2 further patients have been included in the heroin 
group to bring the number of patients in each group to 8. 
Where there was any distinct circulatory effect following 
either morphine or heroin, this was predominantly in the early 
period (0 -10 minutes). In a few instances there was a more gradual 
change with the effects only being marked after some 10 minutes had 
elapsed. Therefore for the purposes of the comparison of the 
circulatory effects of the 2 opiates have been divided arbitrarily 
into early (0 -10 minutes) and late (11 -60 minutes) periods. In both 
periods the maximum positive or negative percentage changes from the 
aQ 
control levels produced by each drug were compared with one another 
using 'Student's' 't' test. 
RESULTS 
Clinical Effects: After the injection of morphine, 2 of the patients 
fell asleep and remained asleep for the rest of the study, while the 
other patients became drowsy. Flushing was not noted in any patient 
and the slight sweating which had been prominent after treatment 
with heroin was not seen after therapy with morphine. No other 
undesirable side effects were observed. 
Circulatory Changes Following Morphine: The sequential changes in 
the circulatory measurements for each patient are shown in figs. 27, 
28, 29 and 30 and the mean changes for the group in Table 12. 
Mean Arterial Pressure: In 7 patients mean arterial pressure fell 
in the early period (0 -10 min). In 5 patients the fall was less tha 
10 mm Hg but at the 5th minute, mean arterial pressure had decreased 
by 14 mm Hg in patient 2 and 18 mm Hg in patient 8. In patient 7 
the mean arterial pressure rose by 12 mm Hg at the 5th minute. The 
changes for the group were not significant (p > 0.05). 
Changes in the late period (11 -60 minutes) were variable and 
showed no significant trend. In 3 patients (2, 4 and 7) arterial 
pressure was lower than in the control period. 
Cardiac Output: In 7 of the patients cardiac output increased soon 























HAEMODYNAMIC CHANGES FOLLOWING INTRAVENOUS INJECTION OF MORPHINE 


























20 10 0 10 20 30 40 50 20 10 0 10 20 30 40 50 
MINUTES 
Fig. 27 
The circulatory effects of morphine in two patients with acute 
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Fig. 28 
The circulatory effects of morphine in 2 patients with acute 
myocardial infarction (AR and McL). 
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0.49 1.min71m -2 in patient 2 and this was observed at the 5th minute. 
In patient 6 the cardiac output fell immediately by 0.52 1.min 1m -2. 
For the group there was no significant change in cardiac output in the 
early period following the administration of morphine (p > 0.05). 
In the late period cardiac output declined to levels similar 
to those of the control period. In patient 6, the initial reduction 
in cardiac output was continued in the late treatment period. However, 
there was no statistically significant difference between the control 
period and the late treatment period (p > 0.05). 
Systemic Vascular Resistance: In 7 of the 8 patients, the calculated 
systemic vascular resistance (p < 0.05) decreased immediately. In 
-1 -5 -2 
patient 2, the fall was of 1050 dyne. sec, cm, m (30 %) below that 
of the control period. After the initial period, systemic vascular 
resistance tended to increase to control levels. In patient 6, the 
calculated resistance increased following the administration of 
morphine and remained elevated throughout the study. 
Heart Rate and Stroke Volume: The mean increase in heart rate after 
the administration of morphine was 5 beats /min (range -3 - + 10 
beats /min) (p < 0.01). As cardiac output also increased, no increase 
in stroke volume was observed. Changes in heart rate and stroke 
volume in the later part of the study were small. 
Mean Right Atrial Pressure: The right atrial pressure in the control 
period ranged from 0 -11 mm Hg. No consistent trend was apparent 
after the administration of morphine. 
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Fig. 29 
The circulatory effects of morphine in two patients with acute 
myocardial infarction. (DI and FR). 
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Fig. 30 
The circulatory effects of morphine in two patients with acute 
myocardial infarction. (TH and ST). 
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Mean Pulmonary Arterial Pressure: The average mean pulmonary 
arterial pressure was 20 mm Hg (range 11 -27 mm Hg). After the 
administration of morphine, there was a small rise in pressure; this 
was significant at the 20th and 30th minutes (p< 0.02). 
Cyclizine and Morphine: Of the 3 patients who were pre -treated with 
cyclizine prior to the administration of morphine, the circulatory 
changes were very similar to those patients who had not been 
pre -treated with cyclizine. Cyclizine itself produced a rise in mean 
arterial pressure but did not prevent a fall in pressure following 
the use of morphine (fig. 31). In one patient (no. 10) there was 
an initial rise in pressure after the administration of morphine 
before the production of hypotension. 
Comparison of the Circulatory Effects of Morphine and Heroin: 
The results detailed above are compared with our own data from 
the published heroin study (MacDonald et al. 1967) and are depicted 
diagrammatically in fig. 32. The maximum change in the variable 
examined is shown for each patient in both early (0 -10 mins) and late 
(11 -60 mins) periods. 
Early Effects: Both drugs produced a small fall in systemic arterial 
pressure. The changes were more marked in the patients who received 
morphine but no statistical difference could be demonstrated between 
the 2 groups (p > 0.05). After the administration of opiates there 
was a significantly greater increase in cardiac output (p < 0.05) in 
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Fig. 31 
Mean aortic pressure in 3 patients with acute myocardial 
infarction treated with cyclizine and morphine. (Patients SO, 
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Comparison of the maximal circulatory changes after morphine 
with maximal changes after heroin (morphine n = 8; heroin n = 8). 
The circulatory effects of heroin have been published (see 
appendix). 
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had heroin. The increase in heart rate was also significantly 
greater in the group who received morphine when compared with the 
heroin treated group (p < 0.01). 
Late Effects: There was no significant difference between the effects 
of the 2 opiates in the late period. 
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DISCUSSION 
The present study confirms that there are variable circulatory 
effects following the administration of morphine. Amongst the 
early effects lasting some 5 -10 minutes, the trend was for the mean 
aortic pressure to fall and the cardiac output and heart rate to 
rise. These findings are similar to those of Thomas et al. (1965) 
but in no patient in the present study was there a profound fall in 
blood pressure. Sapru (1966) measured the changes in the circulation 
fo]lowing a bolus injection of 15 mg of morphine in normal subjects, 
patients with mitral valve disease and patients with left ventricular 
failure. In the immediate period in nearly all patients and normal 
subjects, there was an increase in cardiac output, this being]argely 
rate dependent. There was also a decrease in systemic vascular 
resistance, although arterial pressure only decreased in those 
patients with left ventricular failure. He postulated that this 
group could be under increased sympathetic stimulation and the relief 
of the symptoms produced a reduction in sympathetic discharge. The 
fall in systemic vascular resistance suggested that morphine produced 
vasodilatation in some or all of the vascular bed. Furthermore, 
morphine produced a fall in the calculated cardiopulmonary blood 
volume. The redistribution of blood could account for the therapeutic 
efficacy of morphine in left ventricular failure. 
In the present study no attempt has been made to analyse the 
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changes in cardiopulmonary blood volume because the injection site 
used for the introduction of indocyanine green was in one of the great 
veins and varied from patient to patient and might even vary during 
the study of one patient. Changes in pulmonary arterial pressure 
showed no overall consistent trend, but where the mean pulmonary 
arterial pressure was greater than 25 mm Hg the pressure was reduced 
following the administration of either morphine or heroin. This 
finding is in accordance with Fejfar, Bergman, Fejfarova and Valach 
(1957) and Sapru (1966) and lends support to the idea that opiates 
cause redistribution of total blood volume in left ventricular 
failure. 
The hypotension after opiates has also been attributed to 
histamine liberation. Opiates do have the ability to release 
histamine (Feldberg and Paton 1951). Clinical observers have noted 
weals along veins into which opiates have been injected (Eckenhoff 
and Oech 1960). In dogs anaesthetised with pentobarbital and then 
given meperidine (pethidine) there was a steep fall in blood 
pressure (Van Arman and Sturtevant 1958). Blood samples taken at 
the lowest point of fall were found by guinea pig tests to contain 
large amounts of histamine. The antihistamine drug diphenhydramine 
blocked the hypotension occurring with meperidine, but histamine 
could still be found to be present. However, in the present study 
when the antihistamine drug, cyclizine, was given to 3 patients 
prior to the administration of morphine there was still a slight 
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opiate induced fall in mean arterial pressure. The circulatory 
effects of opiates in man are too variable to make firm conclusions 
but it does seem that histamine liberation is not the universal 
mode of causing circulatory depression. 
Direct myocardial depression has also been invoked as a 
mechanism producing hypotension following opiates (Schmidt and 
Livingston 1933). Subsequent workers (Pur- Shahriari, Mills, Hoppin, 
and Dexter 1967) suggested that although the maximum rate of pressur 
rise of the left ventricle (dp /dt) decreased after morphine the 
decreases paralleled the decrease in left ventricular end -diastolic 
pressure. The author has used opiates during cardiopulmonary bypass 
when the heart is not involved in the circulation and still observed 
a fall in systemic arterial pressure. It would seem therefore that, 
in intact man, direct myocardial depression is not the cause of 
hypotension following opiates. 
In comparing morphine with heroin we chose dose levels which 
are generally accepted as equi- analgesic (Foldes, Swerdlow and 
Siker 1964) although some workers (Reichle, Smith, Gravenstein, 
Macris and Beecher 1962) have suggested that heroin's potency may 
be more than twice as great as morphine. Dundee, Loan and Clarke 
(1966) found that increasing the dose of morphine from 10 to 15 mg 
had a negligible effect on its soporific action, whereas increasing 
the dosage of heroin from 5 to 7.5 mg significantly increased the 
degree of drowsiness. These findings could suggest that heroin 
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may be more than twice as potent as morphine. However, the 
differing time course of action of the 2 drugs may account for minor 
differences found by these workers. 
In this study morphine produced a small initial rise in cardiac 
output and heart rate, changes which were not observed in patients 
who received heroin. There was no difference in the other 
circulatory effects of these 2 drugs and in particular neither 
produced a dramatic fall in arterial pressure. Although the 
circulatory effects of morphine were slightly greater than those of 
heroin, in terms of practical therapeutics, the advantages of heroin 
over morphine seem small. However, the patient numbers in this 
series were small due to the detailed nature of the study and might 
not be representative. It seemed essential to carry out a more 
definitive study on a larger number of patients paying particular 
attention to the changes in blood pressure and heart rate. 
A 'BLIND ' TRIAL OF THE EFFECTS OF MORPHINE 
AMID HEROIN IN ACUTE MYOCARD IAL INFARCTION 
107 
CHAPTER VI 
'BLIND' TRIAL OF CIRCULATORY AND RESPIRATORY EFFECTS 
OF MORPHINE AND HEROIN 
Methods 
In this study the patients were allocated on a randomized basis 
to drug therapy with either morphine or heroin. Twenty -seven 
patients were studied; they had sustained a recent myocardial 
infarction as judged by World Health Organisation (1959) criteria 
within the previous 36 hours. No patient was shocked or had marked 
lung crepitations, they were all in sinus rhythm and no patient had 
prior drug therapy within 12 hours preceding the study. All the 
patients were informed of the nature of the study and their 
permission to undertake the study was obtained. It was explicitly 
stated that this investigation was not part of their standard 
treatment. 
Prepared numbered ampoules containing either morphine 10 mg 
or heroin 5 mg were kept under refrigeration to maintain the purity 
of the heroin. No one involved in the clinical treatment of the 
patient nor in the preliminary evaluation of the results knew to 
which therapeutic group the patients had been allocated. 
The patients were studied in their own beds in the clinical 
108 
investigation and therapy area. The study was conducted in the 
supine position, the head being supported by one pillow. Routine 
patient monitoring was continued, the E.C.G. being used to count the 
heart rate. A small polyethylene catheter was inserted into the 
brachial artery under local anaesthesia. Arterial pressure was 
measured using a Statham strain gauge manometer (P23 Db) and 
recorded on standard recording equipment. Pressure recording was 
continued throughout the study apart from intervals for the sampling 
of arterial blood. A small indwelling needle was placed in a 
peripheral vein to enable the injection of the analgesic without 
disturbing the patient. After the insertion of the catheters, the 
patient was allowed to settle for a period of at least 30 minutes 
before the study commenced. During the study, arterial blood was 
sampled 3 times during the control period and at 10, 20, 30 and 45 
minutes after the start of the injection. The samples were analysed 
for oxygen and carbon dioxide tension and pH. Throughout the study 
the patient was clinically assessed for drowsiness, sleepiness, 
sweating, nausea and vomiting and these clinical features were 
recorded on the patient's proforma sheet at 5 minute intervals. 
Statistical Methods: Biological data is often difficult to interpret 
because of difficulty in achieving satisfactory control periods. Eve 
in the most stable periods, most biological variables have cycling 
time courses. In an attempt to avoid difficulties in time -series 
statistics, a variable control period ranging from 15 to 25 minutes 
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was selected. The precise selection was made on a randomized basis. 
Thus one element of the statistical analysis is the time interval 
between the time of occurrence of an effect, hypothetically due to 
the drug and the (randomly chosen) time of injection of the drug. 
The point of this was to ensure valid statistical confirmation that 
observed changes were true effects of the drug and not due to 
artefact or to physiological changes independent of the drug. 
Statistical analysis of heart rate and blood pressure was 
first made by replotting the individual patient data on a modified 
cumulative total graph. This integrative process is a sensative 
method of detecting small, moderately persistent changes of level 
of the variable being studied (Healey 1968). The precise slope of 
the cumulative plot is unimportant. What is important is a sharp 
change in angle indicating a change in the variable being examined. 
A sharp increase (or decrease) in the angle of slope on the cumulati 
plot indicates a corresponding increase (or decrease) in the 
prevailing level of blood pressure or heart rate. 
An example of cumulative plot (cusum) for an individual 
patient is shown in fig. 33. Changes in mean arterial blood pressure 
are plotted in absolute values and as a cumulative plot. Six minutes 
after the start of the administration of the opiate the cusum plot 
showed a change in angle of approximately 900. This indicates a 
change in the variable being observed. From the cusum plots of 
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Fig. 33 
Changes in mean arterial pressure in one patient before and 
after the administration of an opiate. Blood pressure is plotted in 
absolute value and as a cumulative plot (cusum). There is a marked 
change in the slope of the cusum plot 6 minutes after the start of t 
injection of the opiate. 
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rate and blood pressure were noted. Subsequently standard 
statistical tests were applied. 
RESULTS 
Clinical Effects (fig. 34) 
Of the 27 patients, 14 patients received morphine and 13 
patients received heroin. One patient felt nauseated during the 
study and vomited 20 minutes after administration of the drug. In 
this case the drug administered was heroin. Sweating was more 
commonly observed with heroin than morphine but this difference was 
not statistically significant. Similarly there was no statistical 
difference between the 2 drugs in relation to the drowsiness and 
sleepiness produced. It was sometimes difficult to determine whether 
the patients were truly sleeping or only drowsy, but whether these 
2 effects were assessed separately or together, there was no 
significant difference between the 2 groups when examined by the 
'Chi Square' test. There weee, however, 5 patients who complained of 
a feeling of 'light headedness' 5 minutes after the administration of 
heroin. Only one patient felt 'light headed' after the administration 
of morphine. 
Mean Arterial Pressure: Each trace was analysed by the cusum plot, 
if the plot showed a change in slope of greater than 300 after the 
drug had been administered, it was taken as indicating a positive 
drug effect. As judged on positive reactions on the cusum plots 
8 of the 13 patients who received heroin and 9 of the 14 patients 
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Fig. 34 
The clinical effects of morphine and heroin administered on a 
'blind' basis. (Morphine n = 14; heroin n = 13). 
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administration of the opiate. A fall in mean arterial pressure 
greater than 15 mm Hg occurred in 2 patients who had heroin ( -19 and 
-21 mm Hg) and in 3 patients who had morphine ( -17, -20 and -23 mm Hg) 
The results were also analysed in standard statistical manner. 
The mean changes following therapy with morphine or heroin are shown 
in fig. 35. Both drugs produced a fall in blood pressure, the fall 
occurring within 10 minutes. At this time the mean reduction in 
blood pressure was 8 mm Hg in the morphine treated group and 5 mm Hg 
in the heroin treated group. These changes are small and neither 
they nor their differences are statistically significant. (Table 13). 
When the patients were sat up at the end of the study, changes 
in blood pressure were small and variable. In a number of patients, 
there was slight rise in systolic blood pressure when sat erect. In 
no patient did severe postural hypotension occur (fig. 36). 
Heart Rate: There was no significant difference in the number of 
changes in angle of cusum plots after morphine or heroin. Both drugs 
produced a slight increase in heart rate at approximately 10 minutes 
after the start of the injection -. The changes were small, averaging 
some 2% increase. The mean changes for both groups are shown in 
fig. 37. The greatest individual increase, following morphine, was 
12 beats per min and 14 beats per min following heroin. There was no 
patient who showed marked bradycardia, the greatest individual 
decrease in heart rate (7 beats per min) followed the administration 
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Fig. 35 
Changes in mean arterial pressure following morphine and 
heroin administered on a 'blind' basis. (Morphine n = 14; heroin 






























Alterations in mean arterial pressure after changing from the 












MEAN CHANGES IN HEART RATE 
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Fig. 37 
Changes in heart rate following the administration of 
morphine and heroin. (Morphine n = 14; heroin n = 13). 
Arterial Oxygen Tension: The initial arterial oxygen tensions(Pa02) 
were reduced in all patients, ranging from 43 to 70 mm Hg whilst 
breathing air. The heroin treated group had a lower Pa02 in the 
control period, but this was probably fortuitous as the groups were 
randomly selected. The administration of opiate brought about a 
further decrease in Pa02 (fig. 38). The reduction in Pa02 was most 
marked 10 minutes after the administration of heroin, the mean Pa02 
for the group being reduced by 8 mm Hg. This reduction was most 
marked at 10 minutes and by 30 minutes the level was back to that of 
the control period, The reduction in Pa02 following morphine was 
significantly less than with heroin (p < 0.02) (Table 15). 
Arterial Carbon Dioxide Tension: The mean arterial carbon dioxide 
(PaCO2) prior to the administration of opiates was 40 mm Hg. Ten 
minutes following morphine the mean for the group was increased by 
3 mm Hg and following heroin by 5 mm Hg (fig. 39). There was thus 
a slightly greater increase in PaCO2 following heroin than morphine 
but the changes for the groups were not significantly different 
(Table 16). 
Arterial Hydrogen ion Concentration: Hydrogen ion concentration 
(/ H /) were derived from the measured pH. Both groups had a mean 
/ H / 36 nm/litre prior to the administration of opiates. The 
/ H / in both groups increased after the administration of heroin 
and morphine. There was a greater increase in / H -/ 10 minutes 
















MEAN CHANGES IN ARTERIAL OXYGEN TENSION 
FOLLOWING ADMINISTRATION OF MORPHINE AND HEROIN 
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Fig. 38 
Changes in arterial oxygen tension following the administration 














MEAN CHANGES IN CARBON DIOXIDE TENSION 
FOLLOWING ADMINISTRATION OF MORPHINE AND HEROIN 
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Fig. 39 
Changes in arterial carbon dioxide tension following the 
administration of morphine and heroin. (Morphine n = 14; heroin 
n =13). 
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fashion this increase echieves statistical significance at the 5% 
level (fig. 40) (Table 17). The measured values of pH are shown in 
Table 18. 
Inter -relationship of Data: Dose response curves were constructed 
for the morphine and heroin groups. Within the small range of 
variation in dosage, changes in blood pressure were not related 
(morphine r = 0.163, heroin r = 0.172) to the dose in mg per 
kilogram for either group. 
Similarly changes in blood pressure show a low correlation 
with changes in arterial carbon dioxide tension (morphine r = 0.347, 














MEAN CHANGES IN HYDROGEN ION CONCENTRATION 
FOLLOWING ADMINISTRATION OF MORPHINE AND HEROIN 
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Fig. 40 
Changes in arterial hydrogen ion concentration following the 
administration of morphine and heroin. (Morphine n = 14; heroin 
n = 13). 
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DISCUSSION 
The present study confirms that there are variable but 
relatively minor circulatory effects following the administration 
of morphine or heroin to patients with acute myocardial infarction. 
These findings are the same as those demonstrated in the previous 
chapter and are similar to the findings of Thomas and colleagues 
(1965). However, in no patient in the present study was there a 
profound fall in blood pressure. 
The report of hypotension following morphine by Thomas and his 
colleagues was influenced by the marked hypotension occurring in a 
single patient and in this patient the hypotension was in association 
with marked bradycardia. Although they did not publish detailed 
tables, nor undertake any statistical analysis by using the data 
derived from their published diagrams, a statistical analysis using a 
paired 't' test did not reveal a significant fall in blood pressure 
after morphine. 
No marked postural changes in blood pressure occurred when the 
patients were sat up at the end of the study, the commonest response 
being a slight increase in systolic blood pressure. Eddy and Singh 
(1969) examined the effect of nursing posture in 9 patient after 
acute myocardial infarction. On sitting upright, systolic blood 
pressure increased in 3 patients (2 -12 mm Hg) and decreased in the 
remaining 6 patients (5 -20 mm Hg). In the current study the 
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administration of opiates did not impair normal circulatory 
responses. However, none of the patients had their legs dependent 
whilst sitting up; postural hypotension can occur in normal subjects 
when sat upright with legs dependent (Sapru 1966). 
Changes in heart rate were small both drugs producing a 
slight increase in heart rate. In particular in no patient was there 
a significant bradycardia. In the report by Thomas and his 
colleagues it is difficult to be certain whether the bradycardia in 
the patient with marked hypotension was caused by morphine or by 
some independent physiological mechanism, such as a vasovagal attack. 
Animals and particularly dogs, develop bradycardia after the 
njection of morphine (Kreuger, Eddy and Sumwalt 1941). The effects 
n man are more variable. Papper and Bradley (1942) did not observe 
ny change in heart rate after the intravenous injection of 10 mg of 
orphine to 6 normal subjects. Denton and Beecher (1949) found 
tatistically significant slowing of the pulse rate on 29 subjects 
iven either morphine or 3 methadone derivatives. Drew, Dripps 
nd Comroe (1946) observed an increase in heart rate after morphine 
10 -30 mg) when given intravenously, but when given intramuscularly, 
here was no significant change in heart rate. The bradycardia in 
imals is believed to be a central effect mainly by an action on 
he vagus centre. The excitability of the vagus nerve is increased 
fter morphine, but Allen, Murphy and Meek (1945) showed that 
orphine does not produce bradycardia in decerebrate dogs. Reynolds 
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and Randall (1957) concluded that morphine bradycardia in dogs was 
due to the blocking of cortical impulses which normally exert an 
inhibiting influence on medullary vagal tone. The cardiac slowing 
and arrhythmia observed in normal dogs produced sino- atrial and 
atrio- ventricular heart block (Eyster and Meek 1912). This 
depression of normal conductivity could be reversed by atropine but 
the effects of atropine passed off more quickly than that of morphine 
If bradycardia were a regular feature in man its occurrence 
could be prevented by atropinization. However, the analgesic action 
of the opiate might then be reduced (Gross, Holland, Carter and 
Christensen 1948). The absence of bradycardia in these studies 
involving a total of 25 patients who received morphine and 23 patient 
who received heroin suggests that routine atropinization is 
unnecessary and indeed probably undesirable. 
Opiates usually cause reduced ventilation and cause an increase 
in arterial The increase parallels the degree of respiratory 
depression. Loeschkle, Sweel, Kough and Lambertson (1953) noted a 
mean rise of alveolar PCB of 2.6 mm Hg following 10 mg of morphine 
to 6 normal subjects. Habib (1966) administered morphine in varying 
doses to 13 normal subjects and produced a mean increase in arterial 
PCO2 
of 2.76 mm Hg. In this study the administration of morphine 
caused an increase of 5.4 mm Hg in arterial carbon dioxide tension: 
heroin caused an increase of 6.3 mm Hg in arterial carbon dioxide 
tension. The increase in carbon dioxide tension occurred more 
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quickly in the patients who received heroin than in those who had 
morphine. 
There was a similar early increase in hydrogen ion concentratio 
in those patients who had heroin. This increase was significantly 
greater 10 minutes after drug administration in the patients treated 
with heroin than with those treated with morphine. This suggests 
an earlier onset of action of heroin and is in keeping with the 
observations of Way, Kemp, Young and Grassetti (1960). They showed 
that heroin was rapidly broken to 6 mono- acetyl morphine and that 
this substance was rapidly transferred across the blood brain barrie 
Morphine is transferred more slowly to brain tissue. 
As noted by MacKenzie and colleagues in 1964 and also 
demonstrated in Chapter III, low arterial oxygen tensions occur even 
in "uncomplicated" myocardial infarction. The patients in this 
study all had reduced arterial oxygen tensions and this was reduced 
further after the administration of opiates. This was particularly 
marked after treatment with heroin. The earlier action of heroin 
may be of advantage in the relief of pain but the greater reduction 
in arterial oxygen tension suggests that it is best used when the 
patient is also receiving oxygen. 
The increase in carbon dioxide tension might be expected 
to 
influence the degree of hypotension following opiates. 
Both an 
increased cardon dioxide tension and an increased hydrogen 
ion 
concentration cause vasodilatation of cutaneous, skeletal 
muscle, 
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penal and cerebral vascular beds (Shepherd 1963), In the present 
study no correlation could be found between changes in PaCO2 or 
H /and the degree of hypotension. Moreover, the respiratory 
changes occurred later than the fall in blood pressure. 
Conclusion 
These studies have failed to show a great difference between 
the circulatory effects of morphine and heroin, both drugs producing 
some degree of hypotension, but not marked and not sufficient to 
cause circulatory impairment. The respiratory effects of heroin 
were more marked than those of morphine. It is disappointing that 
the findings do not consistently demonstrate any clear cut advantages 
of one drug over the other. The earlier action of heroin may be of 
advantage.in relief of pain, but the greater depression of arterial 
oxygen tension following its use suggests that it is best used when 
the patient is also receiving oxygen. Increasing the number of 
patients might have produced a statistically significant result bit 
Atkins (1966) has emphasised that a result obtained in this manner 
is unlikely to be of clinical importance. Lasagna in 1964 examined 
the addictive properties, analgesic action and side effects of the 
2 drugs and concluded that there was little difference between 
morphine and heroin. A similar conclusion was reached by Dundee, 
Clarke and Loan (1967) in a study of the side effects of the 2 
drugs. The evidence presented here suggests that there is little 
difference in the circulatory effects of the 2 drugs. Were the 
future supplies of heroin to be threatened, the published evidence 
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suggests that the more traditional and standard morphine is a 
suitable opiate for use in acute myocardial infarction. In terms 
of practical therapeutics these studies have demonstrated no 
important difference between the 2 drugs. 
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CONCLUSIONS AND RECOMMEENDATIONS 
Cardio- respiratory Findings: 
These investigations have shown that nearly all patients with 
recent myocardial infarction have abnormal cardio -respiratory function. 
The more severely ill the patient, the greater is the degree of 
cardiac failure and respiratory abnormality. Even in patients with 
so called 'uncomplicated' myocardial infarction, cardiac output is 
in the low normal range and the mixed venous oxygen saturation is 
decreased. A number of these patients have raised pulmonary arterial 
pressures and most have arterial hypoxia with abnormal ventilation 
perfusion ratios. The mismatching of ventilation and perfusion 
probably results from raised pulmonary venous pressures and decreased 
perfusion to the lung base. The clinical diagnosis of left 
ventricular failure is not always easy and the abnormal cardio- 
respiratory function suggests that sub -clinical left ventricular 
failure is a relatively common finding in acute myocardial infarction. 
The similarity of the abnormal circulatory and pulmonary 
function in patients with clinical left ventricular failure and those 
with shock suggests that severe left ventricular failure is present 
in both groups. The high pulmonary artery pressures recorded in 
cardiogenic shock are in accord with this view. Patients with left 
ventricular failure and cardiogenic shock have severe hypoxaemia and 
the more severely ill the patient, the greater the degree of 
121 
veno- arterial shunting. This shunting is probably a reflection of 
non -functioning gas exchanging units filled with oedema fluid or 
collapse due to peribronchial cuffing or to loss of alveolar 
surfactant. 
In cardiogenic shock the very low cardiac output leads to 
impaired tissue perfusion and to metabolic acidosis. Abnormal 
regional perfusion to areas such as the splanchnic bed may increase 
lactic acidosis because of impaired liver function. The hypoxaemia 
and metabolic acidosis may in turn cause a decrease in myocardial 
contractility leading to a further decrease in cardiac output. 
The finding of a mixed metabolic and respiratory acidosis in 
some patients with failure and shock is worth stressing. This 
condition can only be detected by blood gas analysis and early 
detection and prompt therapy by assisted ventilation can be life 
saving (Anthonisen and Smith 1965, Avery, Samet and Sackner 1970). 
The haemodynamic findings in the patients with cardiogenic 
shock are in close agreement with most published series (Preis et 
al. 1952, Smith, Wikler and Foz 1954, Lee 1957, MacKenzie et al. 
1964, Gunnar et al. 1966, Smith et al. 1967). The report by Shubin 
et al.(1968) is of note for, in developing their prognostic index, 
they divided their patients with cardiogenic shock into two groups, 
the survivors and the non -survivors (Table 2). The haemodynamic 
findings in the survivors fit within the standard deviations of the 
circulatory measurements for group I - the uncomplicated group. The 
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haemodynamic findings in the non - survivors is similar to the findings 
for the Group III patients those with cardiogenic shock. Any report 
of successful therapy in cardiogenic shock must be related to the 
initial haemodynamic status of the patients. 
Simple Monitoring Procedures: 
In many hospitals a detailed haemodynamic study may be 
impossible. What are the simpler variables that can be recorded to 
provide objective evidence of the patients' initial haemodynamic 
status? Blood gas analysis will provide evidence of the patients' 
acid -base status. In cardiogenic shock some measurement of systemic 
blood pressure is required and in most patients this can only be 
assessed with any degree of confidence by arterial cannulation and 
measurement by a pressure transducer. Urine flow will provide some 
index of renal function and this certainly warrants urethral 
catheterisation. The close relationship of mixed venous oxygen to 
cardiac output demonstrated in Chapter III can be used to assess 
total blood flow. Mixed venous oxygen saturation is easily obtained 
by a 'float -in' technique and moreover as pressure measurements are 
also obtained, left heart filling pressures can be assessed. 
Therapy for Shock and for Severe Left Ventricular Failure 
Complicating Acute Myocardial Infarction: 
1. Relief of Pain: The studies presented in Chapters V and VI show 
that recent reports of the hazards of morphine have been exaggerated 
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and that there is little practical difference between morphine and 
heroin. At present morphine is probably a satisfactory analgesic 
for the relief of pain in acute myocardial infarction. 
2. Administration of Oxygen: In patients with left ventricular 
failure and shock, hypoxaemia is likely to be present. Whilst a 
normal physiological response to breathing high concentrations of 
oxygen is unlikely, in nearly all patients there will be an increase 
in arterial oxygen tension. In most patients this will produce almos 
complete oxygen saturation of the arterial blood. As yet there is 
little information on the amount of hypoxia compatible with life. 
Flenley (1967) suggested that therapy should aim to provide a 
partial pressure of oxygen of at least 10 mm Hg at the cellular 
mitochondria. Other workers have suggested that the cellular 
mitochondria operate at oxygen partial pressures of 1 mm Hg (Dickens 
and Neil 1964). It is difficult to confirm or refute this, as 
measurements of mixed venous oxygen tension do not indicate the 
adequacy of oxygen delivery to any one tissue area. Even 
measurement of oxygen tension in effluent blood from one organ does 
not indicate the adequacy of tissue oxygenation, as shunting in the 
micro- circulation can occur. In patients with cardiogenic shock, 
poor tissue perfusion is probably more important than arterial 
hypoxia in inadequate tissue oxygenation. Nevertheless, arterial 
hypoxia is marked and this hypoxia can be partially corrected with 
comparative ease. 
124 
There is a small increase in systemic arterial pressure when 
oxygen is breathed (MacKenzie et al. 1964, Cameron et al. 1966, 
Foster et al. 1969) and cardiac output is little changed. Calculated 
systemic vascular resistance is increased and therefore the work 
load of the heart is increased (Foster et al. 1969). 
However this small increase in work load could easily be 
offset by other potential benefits such as a greater oxygen tension 
in ischaemic myocardium around the infarcted area. As yet there is 
no statistical proof of the benefits of oxygen therapy in myocardial 
infarction and its true value remains somewhat speculative, but for 
the present oxygen tensions are best measured and hypoxia corrected. 
Specific Therapy: It would seem dangerous to attempt to generalise 
in recommending any specific therapy for the treatment of cardiogenic 
shock. Ideally these patients should be managed in a special 
treatment area with facilities for measuring all aspects of 
circulatory function and therapy directed to specific abnormalities. 
On the basis of the findings presented in Chapter III, inotropic 
agents such as digitalis seem logical, but the poor response to 
digoxin documented in Chapter IV and also noted by MacKenzie (1965), 
by Cohn, Tristani and Khatri (1969) and by Gunnar et al. (1970) 
suggest that a successful response is unlikely. Perhaps the 
philosophy of therapy in cardiogenic shock should be to regard these 
patients as on a knife edge. Various therapeutic manoeuvres may 
possibly improve cardiac output and lead to improved tissue 
perfusion 
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with a decrease in metabolic acidosis and an increase in myocardial 
contractility. For this reason, acid -base correction should be 
attempted and an inotropic agent such as digoxin tried. Recently 
there has been increased interest in the inotropic activity of 
glucagon and Puri and Bing (1969) suggested its use in cardiogenic 
shock. Certainly any drug that can increase cardiac output in 
cardiogenic shock will be of value. 
However, the failure of many pharmacological agents to help 
patients in cardiogenic shock has led to investigations of various 
mechanical assistance techniques (Kantrowitz, Krakauer, Butner, 
Freed, Jaron, Rosenbaum, Goodman, 1969). There are many problems 
in design, engineering and physiology of assisted circulation and a 
number of ingeiibus solutions have been devised. However, even when 
total blood flow during assisted circulation seems adequate, abnormal 
regional perfusion may persist, (Muir and Davidson, 1970). 
Although pathological studies have shown that in general 
cardiogenic shock and severe failure are associated with extensive 
infarction, we have no knowledge of the size of the infarcted area 
at the time of onset of cardiogenic shock. If the infarcted area 
was always large then a nihilistic view of future progress in the 
management of cardiogenic shock would be tenable. If on the other 
hand the infarcted area were relatively small, and the low output 
state caused the area to extend, than a much more aggressive policy 
regarding assisted circulation and even surgery would be warranted. 
1.26 
Possible approaches to the problem of initial ventricular damage 
include angiographie studies and the labelling of viable myocardium 
by isotope or tetracycline shortly after the onset of shock. 
Certainly any prospect of lessening the mortality in this common 
condition will be most welcome. 
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I 95 + 11 
- 
3.4 + 0.8 
- 
76 + 14 
- 
Dye dilution (Evans 
et al. II 89 + 20 2.9 + 0.3 50 + 9 : blue). Central injection. 
(1952) 
III 79 + 11 1.8 + 0.4 27 + 7 
SMITH 
I 86 2.4 - . Dye dilution. 
et al. II - - - Peripheral injection. 
(1954) 

















Evans blue peripheral 
injection. 
(1954) 
TIT 73 1.0 - 2950 15.8 7 
Arterial sampling. 
GAMMIL I - 
4.3 104 1272 7.3 11 Evans blue peripheral 
et al. II - 3.0 60 1668 8.4 24 
injection. 
(1955) 
III - - 33 1900 - 2 
Arterial sampling. 
B.P. by sphygmomanometer. 
I 93 4.4 81 942 - 4 
LEE 
II 100 3.2 74 1426 - 5 
(1957) 
III 99 3.0 64 1483 - 2 
BROC K I - 
3.0 70 - - 18 Peripheral injection. 
et al. II - 2.0 43 - - 17 
Earpiece sampling. 
(1959) 
III - - - - - 


































I 92 + 23 
- 
III 53 + 12 
* 
3.8 + 1.5 
2.2 + 0.9 
- 
* 
43 + 18 
- 
21.5 + 6 
** 
26 + 9 
- 
27 + 23 
- 
7.9 + 6.8 
* not indexed 
for body sur- 
face area. 
** mm.Hg.l,min 





III 63 + 13 1.6 + 0.5 
- 
98 + 25 
- 
17 + 5 
- 
2824 + 1000 
- 
9.2 + 4.2 
Zero level 





IIIa 76 + 6 
- 
IIIb 54 + 17 
- 
2.8 + 0.9 
- 
1.3 + 0.6 
- 
82 + 20 
- 
87 + 28 
- 
35 + 12 
- 
15 + 8 
- 
1250 + 625 
- 
1855 + 1027 
- 
7.7 ± 5 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































LEFT VENTRICULAR FAILURE COMPLICATING ACUTE MYOCARDIAL INFARCTION 
CO 






i CHEST X -RAY COMMENTS 
SGOT SCPK 








1 heart block 





































DU F 66 
49 























+ but died 3 
days later 
HA M 165 64 
FI M 68 167 60 1.67 0 + ++ Both bases 
Widespread 
crepitations 






TA F 72 158 63 1.64 0 ++ ++ Ant. transmural 58 - 
Pulmonary 
oedema 
IPPV but died 
Multiple emboli + 
TABLE 5 
SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION 







CHEST X -RAY COMMENTS 



















to therapy + 
Died 24 hours 
later. 
LA M 42 169 68 1.77 + 0 + Both bases 
Anterior 
transmural 
150 - Not done Died 
3 hours + ' 
after admission. 








to therapy + 
Died 14 hours 
later. 






Died 3 hours , 
after admission 







No response to 
therapy 
Died 4 hours 
after admission. 










shock state + 
severe LVF. 
KEY: Ht. in cms. 
Wt. in Kgs. 
+ Died 
S.A. = Body Surface Area in Squ.m. 
TABLE 6 
AUTOPSY FINDINGS IN SHOCK AND LEFT VENTRICULAR FAILURE 













A C R 
HA LVF 420 - 




septal - - Ath - 
TA 
LVF 
350 Normal - inf 
An t. 

























- - - 
Chronic 
bronchitis 
LI Shock 360 
Fibrous pericarditis 







T - - - 




T T - - 












KEY: Heart weight in gms. 
A Anterior descending 
C Circumflex 
R Right coronary 
Ath - Rupture of atheromatous plaque 
T - Thrombosis 
TABLE 7 





















(ml .m2 ) 
Patient Systolic Diastolic Mean 
AD 119 91 103 2.67 85 31 3020 12 
McW 160 65 104 2 .56 80 32 3190 13 
LE 222 122 164 3.28 70 48 3860 18 
SH 233 113 155 2 .29 74 31 5510 17 
McH 173 98 128 1.96 78 25 5200 
CR 118 63 82 2.71 82 33 2440 19 
RI 144 87 114 3.11 80 39 2950 16 
DA loi 66 82 3 .05 72 43 2150 23 
WH 139 91 111 2 .68 92 29 3420 11 
AR 158 89 117 2 .55 87 29 2740 22 
Mc L 136 72 95 2.56 95 26 3010 18 
TH 132 77 101 2 .12 84 26 4000 
ST 112 64 84 2 .63 60 44 2600 
DI 125 81 97 2.82 80 35 2760 20 
DO 101 65 80 2.68 98 27 2460 28 
SC 121 81 92 2.97 69 42 2660 12 
MU 100 69 82 2 .25 87 27 2990 40 
AL 117 81 96 3 .02 92 33 2520 24 
HE 117 72 85 3 .23 124 26 
2080 
RO 119 82 98 2.28 123 18 
3390 25 
FR 105 57 78 3.39 69 47 
1930 12 
SO 139 79 104 2 .43 80 
30 2700 
THO 155 71 104 2.73 
77 39 3040 14 
PE 136 83 109 
2 .55 96 27 
3450 18 
THN 108 23 56 3.42 
60 37 2000 
FL 148 71 102 2.64 
84 31 3090 24 
101 2.71 84 
33 3045 19 
Mean 136 78 
S.E.M. 6 .54 3.69 4.48 0.075 
3.02 1.47 168 
1.56 
S.D. 33 .39 18.83 22.83 0.384 
15.39 7.52 
859 6.96 










































69 40 7.42 94 
62 30 7.52 94 
85 48 7.52 98 
70 36 7.47 97 
79 34 7.48 96 
69 28 7.50 96 
78 36 7.46 96 
58 38 7.42 91 
58 36 7.49 93 
80 35 7.46 96 
65 32 7.49 95 
80 36 7.50 97 
66 40 7.38 92 
57 40 7.40 89 
48 41 7.48 87 
67 35 7.44 94 
54 39 7.53 92 
61 46 7.42 92 
42 30 7.40 77 
58 35 7.43 90 
78 41 7.40 96 
55 39 7.44 90 
65 39 7.48 96 
60 39 7.49 95 
57 36 7.51 92 
55 38 7.48 91 
64 37 93 
2.11 0.88 0.84 
10.77 4.51 4.29 
26 26 26 26 










































































LEFT VENTRICULAR FAILURE 
Patient 
























mean ARTERIAL BLOOD 
Mixed venous blood 
oxygen saturation 
Oxygen 







pH Sa02 Systolic Diastolic Mean 
2 
(l.min.m ) 
CO 84 50 61 1.58 104 15 3110 23 10 47 26 7.49 86 34 17.63 9.25 
HO 162 98 118 2.27 68 33 4160 28 4 59 31 7.53 94 53 19.92 8.17 
SL 105 69 82 2.79 118 24 2330 38 8 45 41 7.35 78 45 21.32 9.18 
VO 117 62 88 2.38 75 32 2920 27 8 59 40 7.47 92 58 19.73 6.71 
WA 120 75 85 1.86 120 15 4140 20 6 56 37 7.42 90 48 20.13 
8.45 
(PAw 12) 
STE 96 46 65 1.72 69 25 3020 20 5 52 50 7.33 84 56 
18.90 5.29 
(PAw 10) 
DU 118 62 79 2.74 73 37 2300 26 7 60 47 7.36 90 55 
17.67 6.18 
HA 80 61 67 1.29 112 12 4150 38 12 73 42 7.34 97 
29 18.56 12.6 
(PAw 30) 
FI 156 94 125 2.12 107 20 4710 24 15 56 58 7.43 90 
- 18.53 - 
TA 122 44 60 2.17 112 19 2200 32 8 31 28 7.53 64 
32 15.54 4.98 
Mean 116 66 83 2.09 96 23 3304 27.6 8.3 54 40 - 86.5 
46 18.79 7.87 
S.E.M. 8.57 5.86 7.17 0.154 6.86 2.70 290 2.08 1.04 3.52 3.18 - 3.02 
3.74 0.513 0.796 
S.D. 27.11 18.54 22.68 0.486 21.04 8.53 917 6.57 3.30 11.14 10.04 - 9.54 
11.22 1.621 2.388 




SHOCK COMPLICATING MYOCARD IAL INFARCTION 
Patient 










































capacity A -V diff. vols.% Systolic y Diastolic Mean 
TU 82 49 63 1.55 84 18 3250 22 3 33 52 52 7.26 80 52 17.41 
_ 
4.87 
PL 55 31 41 1.18 120 10 2600 - 9 74 195 41 7.31 99 - 18.66 - 
LA 62 40 49 1.48 110 13 2920 29 9 45 84 39 7.23 93 35 23.32 13.53 
LI 59 41 47 1.20 74 16 3320 31 11 67 210 27 7.27 100 34 20.05 13.23 
AI 112 85 94 1.20 122 10 6730 24 6 32 61 51 7.26 87 46 20.10 
8.24 
ALE 52 35 40 1.40 96 15 2280 34 11 60 145 37 7.33 99 38 
19.45 11.86 
TA 75 47 55 1.36 107 13 3230 26 8 66 128 19 6.95 79 
32 15.54 7.31 
Mean 71 47 56 1.34 102 13.5 3475 28 8 54 
125 38 - 91 40 19 9.84 
S.E.M. 7.96 6.78 7.08 0.055 6.83 1.13 560 1.84 1.08 6.46 
23.72 4.52 - 3.43 3.20 0.92 1.447 
S.D. 21.05 17.95 18.72 0.148 18.06 2.99 1490 4.50 
2.85 17.10 62.77 11.96 - 9.07 7.84 2.43 
3.55 
N . 7 7 7 7 7 7 7 6 
7 7 7 7 7 7 6 7 
6 
THERAPY IN CARDIOGENIC SHOCK 































* given prior to study 
TABLE 10 
TABLE 11 
PERSONAL CHARACTERISTICS OF PATIENTS TREATED WITH MORPHINE 

























































































































* These patients were pretreated with cyclizine 
TABLE 12 
MEAN CIRCULATORY CHANGES FOLLOWING MORPHINE (10 mgs.) IN 
8 PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. ( +S.E.M.). 





















Cardiac Output 2.59 2.77 2.65 2.50 2.58 2.61 
L.min.m2. ( +0.098) ( +0.155) ( +0.157) ( + 0.127) ( ++0.116) +0.111) ( 
Heart Rate 80.6 83.8 84.7 80.0 80.3 81.8 
beats. min. ( +4.05) ( +5.07) ( +3.72) ( +5.38) ( +5.38) ( +4.62) 
Stroke Volume 33.0 33.6 32.7 31.9 33.0 32.9 
ml .m 2 
(+2.52) (+2.00) (+2.37) ( +1.93) ( +2.22) (+2.22) 
Systemic Vascular 
















Pressure 20.2 21.8 22.5 22.5 22.5 22.0 
( +2.21) (+2.44) (+2.68) ( +2.17) ( +2.79) (+2.86) 
mm.Hg. - - - - - - 
Right Atrial 
Pressure 5.6 6.0. 4.6 6.4 5.3 5.3 
mm.Hg. 
( +1.59) ( +1.38) ( +1.55) ( +1.41) ( +1.99) ( +1.66) 
TABLE 13 
CHANGES IN MEAN ARTERIAL PRESSURE FOLLOWING MORPHINE AND HEROIN 
Patient No. Control 
Time (Minutes) 
10 20 30 45 
MORPHINE mm Hg 
4 105 96 96 97 98 
5 76 71 73 73 73 
8 96 90 96 93 91 
9 89 82 80 79 76 
10 55 46 51 50 56 
11 123 100 98 105 100 
14 70 61 64 62 60 
16 67 65 63 65 67 
17 113 93 98 102 105 
21 88 87 90 90 73 
22 84 91 83 79 75 
23 90 82 82 85 82 
26 64 68 68 68 66 
27 142 125 112 116 116 _ 
, 
Mean 90.14 82.64 8.243 83.14 81.29 
S.E. + 6.48 + 5.24 +4.57 + + 4.97 + 4.82 
S.D. +24.26 +19.60 +17.08 +18.60 +18.03 
n. 14 14 14 14 .14 
HEROIN 
67 65 66 65 66 1 
2 78 83 78 79 75 
3 88 82 77 76 75 
6 99 94 96 96 97 
7 97 99 108 102 96 
12 93 100 100 92 93 
13 76 78 77 71 70 
15 88 80 86 88 88 
18 68 68 70 70 70 
19 112 105 102 101 101 
20 110 89 90 93 98 
24 78 70 76 83 82 
25 94 75 77 76 75 
4 
Mean 88.31 83.69 84.85 84.46 83.54 
S.E. + 4.0 + 3.58 + 3.67 + 3.62 + 3.45 
S.D. +14.45 +12.90 +13.22 +13.06 +12.43 
n. 13 13 13 13 13 
TABLE 14 
CHANGES IN HEART RATE FOLLOWING MORPHINE AND HEROIN 
Patient No. 
Time (Minutes) 
Control 10 20 30 45 
MORPHINE beats /min 
4 98 104 103 106 103 
5 78 81 83 79 81 
8 103 102 103 101 99 
9 56 58 58 54 56 
10 68 66 68 68 66 
11 74 82 81 77 77 
14 71 73 70 75 69 
16 79 79 77 74 77 
17 79 79 77 78 77 
21 67 71 67 66 67 
22 88 93 91 92 88 
23 48 51 51 49 49 
26 80 77 78 78 76 
27 104 99 96 96 96 
Mean 78.0 79.6 78.7 78.0 77.2 
S.E. + 4.3 + 4.2 + 4.1 + 4.3 + 4.1 
S.D. +16.3 +15.8 +15.6 +16.4 +15.6 
n. 14 14 14 14 14 
HEROIN 
67 65 66 65 62 1 
2 61 65 60 60 58 
3 84 86 86 84 84 
6 93 96 96 92 94 
7 65 72 65 66 59 
12 65 66 64 64 62 
13 67 68 66 64 60 
15 58 56 56 58 58 
18 76 77 76 73 73 
19 89 88 91 89 89 
20 77 91 74 91 87 
24 72 70 68 70 71 
25 71 64 68 71 68 
Mean 72.6 74.2 72.0 72.6 71.1 
S.E. 2.9 3.4 3.3 3.3 3.6 
S.D. 10.7 .2.2 12.1 12.1 13.0 
n. 13 13 13 13 13 
TABLE 15 
CHANGES IN ARTERIAL OXYGEN TENSION FOLLOWING MORPHINE AND HEROIN 
Patient No. Control 
Time (Minutes) 
10 20 30 45 
. 
MORPHINE mm Hg 
4 57 54 57 57 56 
5 52 47 55 47 54 
8 62 55 55 53 51 
9 75 69 61 69 66 
10 67 69 67 63 61 
11 68 49 55 63 66 
14 60 57 i 56 54 60 
16 65 70 66 61 63 
17 69 55 58 62 64 
21 62 60 62 65 63 
22 63 68 67 68 65 
23 76 76 73 75 78 
26 76 74 67 68 66 
27 54 53 56 68 62 
Mean 65.00 61.14 61.07 62.35 62.5 
S.E. +2.04 +2.56 +1.59 +2.00 +1.72 
S.D. +7.64 +9.58 +5.95 +7.50 +6.45 
n. 14 14 14 14 14 
HEROIN 
49 43 47 48 43 1 
2 65 53 68 61 69 
3 51 44 , 53 50 52 
6 51 49 49 47 56 
7 65 55 61 60 - 
12 56 52 53 55 53 
13 62 60 ; 63 78 67 
15 57 54 54 62 47 
18 57 55 57 57 54 
19 56 51 51 58 53 
20 63 39 45 43 48 
24 64 65 65 76 65 
25 75 53 58 57 57 
, Mean 54.15 51.77 55.69 57.84 55.33 
S.E. +2.02 +1.93 +1.96 +2.86 +2.33 
S.D. +7.28 +6.95 +7.08 +10.30 +8.08 
n. 13 13 13 13 12 
TABLE 16 
CHANGES IN PCO2 FOLLOWING MORPHINE AND HEROIN 
Patient No. Control 
Time (Minutes) 
10 20 30 45 
MORPHINE mm Hg 
4 35 39 39 39 38 
5 35 37 37 41 50 
8 35 39 40 40 40 
9 39 46 49 49 50 
10 37 47 44 47 46 
11 44 50 51 52 50 
14 42 50 52 51 53 
16 45 41 49 54 56 
17 32 37 37 35 36 
21 38 39 39 39 41 
22 39 42 42 42 45 
23 45 48 51 51 46 
26 42 43 48 47 48 
27 42 42 42 39 42 
Mean 39.28 42.86 44.29 44.7 45.78 
S.E. +1.11 +1.22 +1.48 +1.63 +1.56 
S.D. +4.16 +4.59 +5.53 +6.09 +5.83 
n. 14 14 14 14 14 
HEROIN 
30 37 36 36 39 1 
2 45 54 49 47 50 
3 34 39 38 38 39 
6 36 36 39 38 40 
7 40 49 46 48 - 
12 39 45 46 46 44 
13 41 42 48 47 48 
15 51 50 59 59 63 
18 43 48 48 49 51 
19 35 38 40 42 42 
20 43 53 55 57 55 
24 40 48 50 50 49 
25 47 51 52 53 54 
Mean 40.31 45.38 46.62 46.92 47.83 
S.E. +1.58 +1.75 +1.90 +1.97 +2.13 
S.D. +5.71 +6.30 +6.85 +7.09 +7.39 
n. 13 13 13 13 13 
TABLE 17 
CHANGES IN /-1P. / FOLLOWING MORPHINE AND HEROIN 
Patient No. Control 10 
MORPHINE n mo1.1 
4 33 37 
5 33 37 
8 32 33 
9 35 38 
10 33 37 
11 38 40.5 
14 35 37 
16 35 33 
17 43 46.5 
21 34.5 35 
22 36 37 
23 38 40.5 
26 38 39 
27 40 40 
Mean 35.96 37.89 
S.E. +0.83 +0.92 
S.D. +3.10 +3.44 
n. 14 14 
HEROIN 
33 37 1 
2 34.5 40.5 
3 35 40 
6 35 36 
7 37 41.5 
12 33 38 
13 30.5 34.5 
15 40.5 40.5 
18 40 40.5 
19 32 34.5 
20 40.5 47.5 
24 36 40 
25 41.5 45.5 
Mean 36.04 39.75 
S.E. +1.00 +1.06 
S.D. +3.60 +3.80 
n. 13 13 
Time (Minutes) 
20 30 45 
37 37 37 
34.5 36 37 
32 32 33.5 
39 39 40.5 
35 37 37 
40.5 43 41.5 
39 38 36 
33 38 37 
49 49 52 
34.5 34.5 35 
38 38 38 
40 40 39 
39 37 38 
40 40.5 42.5 
37.39 38.50 38.85 
+1.13 +1.07 +1.20 
+4.24 +4.00 +4.50 




















































CHANGES IN ARTERIAL pH FOLLOWING MORPHINE AND HEROIN 
Patient No. Control 
Time (Minutes) 




































































































7.48 7.43 7.46 7.44 7.43 
7.46 7.39 7.43 7.45 7.45 
7.45 7.40 7.44 7.44 7.45 
7.45 7.44 7.44 7.45 7.45 
7.43 7.38 7.39 7.38 - 
7.48 7.42 7.42 7.43 7.44 
7.51 7.46 7.44 7.46 7.46 
7.39 7.39 7.36 7.33 7.40 
7.40 7.39 7.39 7.39 7.39 
7.49 7.46 7.45 7.45 7.46 
7.39 7.32 7.33 7.31 7.32 
7.44 7.40 7.39 7.39 7.42 
7.38 7.34 7.33 7.34 7.35 
Reprinted from THE LANCET, May 20, 1967, pp. 1070 -1074 
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Summary The intravenous injection of morphine 
for the relief of pain in patients with acute 
myocardial infarction is known to cause significant, and 
occasionally severe, hypotension. A standard thera- 
peutic dose (5 mg.) of heroin administered intravenously 
to eight patients with acute myocardial infarction caused 
little change in the cardiovascular system. The analgesic 
and sedative effects of the drug were adequate and no 
undesirable side -effects were observed. Heroin may be 
preferable to morphine in the treatment of patients with 
acute myocardial infarction. 
Introduction 
THE effective relief of pain and anxiety is an essential 
part of the treatment of patients with acute myocardial 
infarction. Morphine has long been the drug of choice 
for this condition in both hospital and general practice. 
The British Medical Journal (1966a) drew attention to 
the undesirable side -effects of morphine including the 
2 
striking changes which it may induce in the hamo- 
dynamic state. The most important of these is a fall in 
systemic arterial pressure which may be severe even 
after small doses of the drug (Thomas et al. 1965). 
Despite these disadvantages, it was concluded that 
morphine seemed " likely to retain its important place 
in the treatment of acute myocardial infarction ". The 
British Medical Journal (1966b) further suggested that 
heroin should be used in the severely ill patient, but 
cited no evidence in support of this statement. Douth- 
waite (1953) suggested that heroin is less likely to give 
rise to nausea and vomiting. The effects of heroin on 
the circulation do not seem to have been reported. 
We have assessed the effects of intravenous heroin on 
the circulation as far as could be determined without 
added risk to patients already in jeopardy as a result of 
acute myocardial infarction. 
Patients and Methods 
Clinical Data 
We investigated eight patients whose personal characteristics 
and clinical details are shown in table I. All eight patients had 
sustained an acute myocardial infarction by World Health 
Organisation (1959) criteria within the previous 48 hours. 
One patient (no. 3) was shocked. Three others (nos. 3 -5) 
complained of ischmmic chest pain at the start of the study 
and one of these felt sick. One patient (no. 4) was in first - 
degree heart block with intermittent Wenckebach periods. 
Patient no. 3 had frequent ventricular extra- systoles before 
and during the study. The others were in normal rhythm 
although all had occasional ventricular ectopic beats. Two of 
the patients were on anticoagulant therapy (phenindione) but 
none had received any other drug within the 12 hours pre- 
ceding the investigation. No patient had an oral temperature 
above 99.2 °F (37.2 °C). 
Plan of Investigation 
The investigations were carried out with the patients in 
their own beds in a specially adapted side room of a general 
ward. The first six patients (nos. 1 -6) were studied supine 
with one pillow supporting the head, and two patients (nos. 7 
and 8) were studied with the head of the bed raised 10 degrees 
above the horizontal plane. Control observations were made 
in each patient over a period of 20 minutes. 5 mg. of heroin 
diluted in 10 ml. of saline solution was then injected into the 
right atrium over a period of five minutes, observations being 
made during this period and for a further 50 minutes in the 
first six patients and for 30 minutes in the other two. The 
electrocardiograph was recorded continuously throughout. 



































































































































































































































































































































































































pressure were interrupted only for sampling of arterial and 
mixed venous blood. The cardiac output was measured at 
5- minute intervals during the control period, 2.5 minutes and 
5 minutes after the start of heroin injection and at 5- minute 
intervals thereafter. Arterial blood was withdrawn at the 
beginning and end of the control period and at 5, 10, 20, 30, 
and 50 minutes after the start of injection for estimation of 
oxygen capacity, oxygen tension (Pao2), carbon- dioxide tension 
( Pac02), and pH. Central venous blood was obtained at the 
same intervals so that the whole -body oxygen uptake could 
be calculated by the Fick principle. 
Techniques 
Aortic pressure was recorded through a 55 cm. nylon 
catheter inserted percutaneously into the left brachial artery 
and advanced into the aortic arch. The right atrial pressure 
was recorded through one lumen of a triple -lumen catheter, 
the tip of which was advanced into the right atrium from the 
right basilic vein. A fine nylon catheter was " floated " into 
the pulmonary artery by the technique described by Bradley 
(1964). All intravascular pressures were transduced by 
Statham ` P23Db ' strain -gauge manometers. Cardiac output 
measurements were made by a standardised indicator dilution 
technique using indocyanine -green injections into the right 
atrium and sampling from the aorta through a Waters 
` XC 300 ' A cuvette densitometer. Details of these techniques 
have been described elsewhere (Macdonald, Sapru, Taylor, 
and Donald 1966, Taylor 1966). The electrocardiograph, 
intravascular pressures, and dye -dilution curves were dis- 
played continuously on a 17 in. oscilloscope so that any 
significant change could be detected immediately and 
suitable action taken without delay. 
Pa02, Pac02, and pH were measured in a combined cuvette 
apparatus (Instrumentation Laboratories Inc., Boston, Massa- 
chusetts). In our hands, the standard deviation about the 
regression line for the range of measurements in this study 
was less than 3 mm. Hg, and pH duplicated to 0.005. 
Student's t test was applied to the differences between the 
mean values during the control period in each patient (nos. 
1 -6) and measurements recorded at 5, 10, 20, 30, 40, and 50 
minutes after the start of injection, the null hypothesis being 
that the difference would be zero. 
Results 
Clinical Observations 
After the administration of heroin, six patients fell 
asleep within 15 minutes and remained so for the next 
hour. The other two felt " pleasantly drowsy ". The 
pain experienced by patients 3 -5 was rapidly relieved. 
The one patient who complained of severe nausea during 
the control period fell asleep and, on waking at the end 
5 
of the investigation, felt completely well. At no time 
during the studies did the clinical state of any patient 
give cause for alarm and no undesirable side -effects 
were observed. 
Circulatory Changes 
The sequential changes in the circulatory measurements 
for each patient are shown in fig. 1. The mean changes 
for the six patients who were investigated horizontally 
are shown in fig. 2. The results in this group will be 
considered first. 
Circulatory Changes, Patient Horizontal 
Mean aortic pressure. -The mean fall was 5 mm. Hg 
at the 5th and 10th minutes after the start of injection 
(r = <0.05). Thereafter the pressure returned to and 
remained at normal levels. This was a consistent trend 
except in patient no. 6 in whom the mean pressure con- 
tinued to decline gradually for 30 minutes before return- 
ing towards control values. The lowest level in this 
patient was 16 mm. Hg below the control observations. 
Cardiac output. -No significant trend was observed 
after the administration of heroin. Four patients showed 
small variable changes, which were of no practical 
importance. In one patient (no. 6), the cardiac output 
rose by 0.26 litre per minute per sq. m. and then fell 
steadily to 0.5 litre per minute per sq. m. below control 
levels. One patient (no. 4) showed a sustained increase 
reaching a maximum of 0.56 litre per minute per sq. m. 
above control levels 30 minutes after the start of infusion. 
Systemic vascular resistance. -In the shocked patient 
(no. 3), there was a small but progressive increase of 
systemic vascular resistance after the administration of 
heroin. In the other five patients, it tended to fall 
slightly but this fall was transient in all except patient 
no. 4 in whom the systemic vascular resistance was raised 
(4160 dynes per second per cm.5 per sq. m.) during the 
control period. The mean change was not significant 
(r > 0.20). 
Heart -rate and stroke volume. -Heroin had little effect 
on the heart -rate. Minor variations of less than 10 beats 
per minute were observed except in patient no. 3. Her 
heart-rate fell by 16 beats per minute due to a decrease 
in the number of ventricular extrasystoles. Changes in 
stroke volume were similarly small and variable (r> 0.50). 



























































































































































































































































































































































































































































































































































































atrial pressure was 4-8 mm. Hg in patients 1 -5. In 
patient no. 6, it was 0 mm. Hg. After the administration 
of heroin, the mean right atrial pressure tended to rise 
slightly but in three cases this increase was preceded by 
a fall of 1 -2 mm. Hg in the first 5 minutes of infusion. 




















IO 20 50 40 50 
TIME -MINUTES 
Fig. 2 -Mean circulatory changes in six patients with acute 
myocardial infarction. 
2 mm. Hg. The changes for the group were not signifi- 
cant (P > 0.10). 
Mean pulmonary arterial pressure. -The average mean 
pulmonary arterial pressure was 28.5 mm. Hg (range 
23-43 mm. Hg). No consistent trend was apparent after 
heroin injection. In the three patients (nos. 2, 3, and 5) 
with the highest mean control pressures of 43, 36, and 
33 mm. Hg, respectively, there were decreases of 8, 10, 
and 5 mm. Hg. Patient no. 1 with a control pressure of 
23 mm. Hg showed an increase of up to 8 mm. Hg after 
the injection, while in the other two patients (nos. 4 and 
6) no change was seen. 
The mean oxygen uptake, calculated from the cardiac 





















































































































































































































































































































































































































































































































































































































































































































































control period was 166 ml. per minute per sq. m. (range 
of 120 -200). There was no significant change following 
the administration of heroin. 
Circulatory Changes, Patient Tilted 
In patients 7 and 8, the drug was administered while 
the patient was tilted at an angle of 10 degrees. There 
were no striking changes in any of the above measure- 
ments even in patient 7 who was notably hypotensive. 
Arterial Blood gases and pH (table it) 
The mean Pao2 of 58.6 mm. Hg (range 45 -78 mm.) 
fell to 54.2 mm. Hg (range 38 -69 mm. Hg), within 5 
minutes of the start of injection. This decrease, though 
small, was significant (r <0.05). Thereafter, it tended 
to return to control levels. The mean Paco2 was 38.6 
mm. Hg (range 31 -46 mm. Hg) in the control period, 
and was significantly increased in all observations after 
heroin. The change was greatest 10 minutes after the 
start of injection when the average PaCo2 was 45.3 mm. 
Hg (range 37 -56 mm. Hg) (P <0.001). The mean pH 
was 7.48 (range 7.35 -7.53) in the control period and 
decreased consistently after heroin. The most significant 
decrease (r <0.001) was found 10 minutes after the start 
of injection when the average pH was 7.43 (range 
7.30- 7.52). 
Discussion 
In acute myocardial infarction which is not immediately 
fatal, the ability of the heart to perform its normal work 
load and to respond to changes in the demands made 
upon it is impaired, to a greater or lesser extent. Ideally, 
any drug which is used to relieve the pain in this con- 
dition should not adversely affect the circulation either 
by increasing the work load of the heart or by decreasing 
it at the expense of adequate tissue perfusion. 
Moor (1930) prescribed intravenous morphine for the 
treatment of myocardial infarction, and over the years 
this drug has become standard therapy. Although the 
analgesic efficacy of morphine is undisputed, its sedative 
effect is frequently impaired by a tendency to cause 
distressing nausea and vomiting (British Medical Journal 
1953, Christie et al. 1958, Dundee et al. 1965). Furthermore. 
the act of vomiting produces a striking increase in cardiac 
output and mean aortic pressure (Sapru 1966). These 
abrupt changes may easily precipitate a crisis in a patient 
who has only a small cardiac reserve. Heroin is approxi- 
10 
mately twice as potent weight for weight as morphine 
(Reichle et al. 1962, Goodman and Gilman 1965). In equiva- 
lent pain -relieving doses, it is reputed to be less nauseating 
(British Medical Journal 1953, Douthwaite 1953). We 
found the analgesic effect in the three patients with pain 
was entirely adequate while the sedative effects in all 
eight patients were excellent. No nausea, vomiting, or 
other unpleasant side -effects were observed. 
Heroin had no dramatic effect on the circulation. The 
only consistent finding was a small fall in mean aortic 
pressure in the first 10 minutes after injection. This was 
of little practical importance and contrasts sharply with 
the changes after intravenous morphine given to patients 
with acute myocardial infarction (Thomas et al. 1965). 
The dosage used in their study ranged from 10 mg. to as 
little as 3 mg. of morphine. They did not give tables of 
their measurements but it seems from their diagrams that 
most of their patients showed significant variations in 
heart-rate, cardiac output, or blood- pressure, which 
were independent of the total dose administered. 
The precise action of heroin is outside the scope of 
this investigation which, because of the limited intra- 
vascular techniques that can be safely used in patients 
with acute myocardial infarction, was designed as a 
practical assessment rather than a pharmacological 
experiment. However, there is a tendency for the mean 
aortic pressure, cardiac output, systemic vascular resist- 
ance, and right atrial pressure to decrease in the first 
10 minutes after heroin injection. These changes, 
though much smaller and of shorter duration, are the 
same in direction as those found by Sapru (1966) after 
injection of morphine. The reason for this quantitative 
difference between the circulatory effects of the two 
drugs is not clear. Heroin is rapidlyhydrolysed to the active 
metabolite 6- monoacetyl morphine which is later converted 
to morphine. It may be that 6- monoacetyl morphine, 
which passes more rapidly across the blood -brain barrier, 
has less effect on the circulation. The blood -gas studies 
show that heroin, like morphine, is a significant respiratory 
depressant. It seems unlikely that the initial slight 
decrease in mean aortic pressure could be due to the 
increase in Paco2 since this remained above control 




Heroin has provided adequate analgesia and sedation 
without unpleasant or harmful side -effects and with little 
effect on the circulation in eight patients with acute 
myocardial infarction. At a time when the future avail- 
ability of the drug in the U.K. is once again being 
debated, these preliminary studies suggest that heroin 
may be preferable to morphine in the, treatments of 
patients with myocardial infarction. 
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